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Neuromelanin organelles are specialized autolysosomes that
accumulate undegraded proteins and lipids in aging human
brain and are likely involved in Parkinson’s disease
Fabio A. Zucca 1, Renzo Vanna 1,2, Francesca A. Cupaioli1, Chiara Bellei1, Antonella De Palma1, Dario Di Silvestre1, Pierluigi Mauri1,
Sara Grassi3, Alessandro Prinetti3, Luigi Casella4, David Sulzer 5,6,7 and Luigi Zecca1,5
During aging, neuronal organelles ﬁlled with neuromelanin (a dark-brown pigment) and lipid bodies accumulate in the brain,
particularly in the substantia nigra, a region targeted in Parkinson’s disease. We have investigated protein and lipid systems
involved in the formation of these organelles and in the synthesis of the neuromelanin of human substantia nigra. Membrane and
matrix proteins characteristic of lysosomes were found in neuromelanin-containing organelles at a lower number than in typical
lysosomes, indicating a reduced enzymatic activity and likely impaired capacity for lysosomal and autophagosomal fusion. The
presence of proteins involved in lipid transport may explain the accumulation of lipid bodies in the organelle and the lipid
component in neuromelanin structure. The major lipids observed in lipid bodies of the organelle are dolichols with lower amounts
of other lipids. Proteins of aggregation and degradation pathways were present, suggesting a role for accumulation by this
organelle when the ubiquitin-proteasome system is inadequate. The presence of proteins associated with aging and storage
diseases may reﬂect impaired autophagic degradation or impaired function of lysosomal enzymes. The identiﬁcation of typical
autophagy proteins and double membranes demonstrates the organelle’s autophagic nature and indicates that it has engulfed
neuromelanin precursors from the cytosol. Based on these data, it appears that the neuromelanin-containing organelle has a very
slow turnover during the life of a neuron and represents an intracellular compartment of ﬁnal destination for numerous molecules
not degraded by other systems.
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INTRODUCTION
Electron microscopy studies of neurons of numerous brain regions
have demonstrated that organelles containing neuromelanin (NM)
exhibit abundant clear “lipid bodies” (sometimes referred to as
“lipid droplets” in the literature, although this term is widely used
for a different lipid storage organelle) and a dark electron-dense
matrix.1–3 The number of these organelles and the concentration
of NM pigment increase linearly during aging.3–6 These organelles
are highly concentrated in dopamine (DA) neurons of the
substantia nigra (SN) (Fig. 1a,b,c) and norepinephrine neurons of
locus coeruleus,2,5,6 brain regions strongly targeted in Parkinson’s
disease (PD).7,8 The pigments of these organelles are a family of
compounds formed by a melanic, aliphatic, and protein compo-
nents with variable ratios.9 NM pigment also accumulates large
amounts of metals, further conﬁrming that these organelles
continuously accumulate in aging due to very slow turnover.3
The formation of NM appears to provide a protective
process,3,10 but the amount of NM accumulated in neurons is
related to their vulnerability in PD.8,11,12 Due to its biochemical
properties, NM has long been suggested as a critical factor
underlying neuronal vulnerability in PD.8 Indeed, NM is suggested
to play a dual role, both toxic and protective, that is determined
by the cellular context and conditions.13,14 The synthesis of NM is
neuroprotective since it removes from the cytosol the reactive/
toxic quinones that would otherwise induce neurotoxicity.10 NM
further plays a protective role by chelating potentially toxic
metals, including Fe, Zn, Cu, Al, Cr, Mo, Pb, and Hg (refs. 3,15), drugs
and organic toxicants.16–18 However, NM can play a toxic role
when released by degenerating neurons of the SN during PD:
under these conditions, NM acutely discharges high amounts of
metals and organic chemicals accumulated over many years of
life. NM released by degenerating neurons in PD activates
microglia, producing reactive and pro-inﬂammatory molecules
that induce further neuronal death and release of NM, thus
establishing a vicious cycle of neuroinﬂammation and neurode-
generation.19 The activation of microglia by NM can drive antigen
presentation by SN and locus coeruleus catecholaminergic
neurons, a response that may play a crucial role in PD
pathogenesis.20 NM can also stimulate dendritic cells in vitro
inducing their maturation.21
The structure of the melanic component is different in various
types of NM pigments,9,22 and multiple features of NM structure,
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as well as protein and lipid composition of NM-containing
organelles, remain incompletely characterized. Indeed, the protein
components of NM-containing organelle have been partially
characterized, and these are consistent with its lysosomal
nature.23,24 However, the characterization of proteins belonging
to different portions of the NM-containing organelle and their
localization are yet to be clariﬁed, although this knowledge is
fundamental to understanding the complex nature of these
organelles. Current data do not indicate the mechanisms of NM
accumulation, protein and lipid transport and accumulation within
the organelle, or the role of these organelles inside neurons. It is
further unknown whether the NM pigment is synthesized within
these organelles or transported inside after synthesis elsewhere.
Here we investigate the proteins and lipids of NM-containing
organelles from human SN and their accumulation inside these
organelles. The NM-containing organelle analyzed here is a
paradigmatic case in which an abundant accumulation of the
melanic pigment occurs; however, the presence of these
organelles is observed throughout the entire brain as a result of
physiological aging.3
The aim of this study is to perform an extended characterization
of proteins and lipids of NM-containing organelles from human
SN. To this end, we required highly puriﬁed preparations of NM-
containing organelles. In order to control contaminations and to
avoid the loss of some proteins or lipids, we prepared three types
of NM-containing samples with different procedures and com-
pared the data obtained by liquid chromatography-mass spectro-
metry (LC-MS) determinations on these samples. To further
conﬁrm the reliability of our results, independent determinations
were also made by immunoelectron microscopy (IEM), western
blotting (WB), and thin-layer chromatography (TLC) in addition to
LC-MS. In this study, protein proﬁles were analyzed (i) in three
preparations derived from human SN, the organelles containing
NM pigment (ORG), NM pigment puriﬁed from SN tissues (TIS-NM),
and NM pigment isolated from organelles (ORG-NM) using LC-MS;
(ii) by WB of ORG samples; and (iii) by IEM of SN tissue slices. The
lipid pathways were analyzed by TLC and LC-MS analyses of lipid
molecules associated with lipid bodies and with NM pigment, and
through characterization of transport proteins and related
enzymes by LC-MS, IEM, and WB analyses.
The combination of proteomics, lipidomics, imaging, and
biochemical techniques in the study of NM-containing organelles
is required for a detailed description of the molecular mechanisms
associated with brain aging and neurodegeneration. Previous
studies have only partially addressed these issues.23–27 The
identiﬁcation of these pathways is crucial for elucidating the
processes mediating neuronal survival and vulnerability during
aging and PD.
RESULTS
NM organelles proteins were identiﬁed by analyzing three types of
samples: isolated NM-containing organelles, NM puriﬁed from SN
tissues, and NM puriﬁed from NM-containing organelles
The purpose of this study is to describe the proteins present inside
the NM-containing organelles, and then distinguish those
covalently bound to NM pigment from those not attached to
NM. The proteins bound to NM pigment may be more related to
the initial steps of NM synthesis, while those not bound to NM
pigment may play a role in the membrane, transport, and storage
processes involved in NM-containing organelle formation. There
are several experimental limitations in the analyses of proteins in
NM-containing organelles. In human post mortem brain, the
membranes of organelles undergo degradation, and their
constituents can be released from organelles to the cytosol, and
conversely, the organelles can be contaminated by cytosolic
components. Furthermore, when processing brain tissues for
isolation of ORG samples, the membranes can be broken with
consequent mixing of intra- and extracellular proteins. The
washing procedure of ORG isolation can moreover change the
protein content of organelles due to membrane damage. The
native proteins detected by analyzing ORG samples therefore
likely underestimate the original protein content, while there may
be an increased number of proteins due to contamination.
Thus, we also isolated TIS-NM for protein characterization by LC-
MS. During the isolation process of TIS-NM, membranes are
broken and additional proteins are likely aspeciﬁcally adsorbed by
NM pigment. TIS-NM was prepared following the procedure
reported by several previous studies.3,9,28 Here, proteinase K was
employed during the isolation procedure of TIS-NM from SN tissue
as it was necessary to remove non-speciﬁcally associated proteins.
A preliminary study reported that TIS-NM isolated without
proteinase K contained a higher percentage of extracellular and
nuclear proteins than TIS-NM isolated with proteinase K, indicating
a higher contamination by non-speciﬁc proteins during the
isolation procedure.29 Indeed, the isolation of NM pigment
without proteinase K generates macroaggregates difﬁcult to
purify. These macroaggregates could contain proteins originating
from cytosol, other organelles and tissue compartments which
interact and bind to NM pigment and NM-conjugated proteins
during isolation, that may form S–S bridges and other means of
conjugation. In this case, this kind of sample would contain
proteins not related to the NM-containing organelle. This
procedure and its rationale are described in detail in previous
studies (Methods).3,9 We elected to prepare the TIS-NM samples
with proteinase K as this type of sample was used in several
previous studies, and so necessary for comparison of the present
data with previous reports.3,9,28
Finally, to overcome the above experimental limitations, we
further analyzed proteins in ORG-NM samples, i.e., the NM
pigment isolated from ORG samples. This type of NM was puriﬁed
by disrupting and eliminating the membranes and the soluble
portion from ORG samples, in order to study the protein
components strictly associated with NM pigment, without
exposure to contaminants from other intraneuronal components.
This experimental design was in our opinion the best approach
to exclude contaminating proteins. In addition, this approach
avoided loss of some proteins of the NM-containing organelle, a
central aspect of this study, beyond preventing contamination.
We then compared the three sets of proteins observed in the
following preparations (Supplementary Fig. 1): two independent
samples of ORG, two independent samples of TIS-NM, and two
independent samples of ORG-NM (Methods). ORG, TIS-NM, and
ORG-NM samples were analyzed by a total of 15 LC-MS analyses.
As a result, 1020 proteins were identiﬁed and a group of 293 was
selected as representative of the samples based on their amount
(Table 1), as estimated from the number of spectral count (SpC),
deﬁned as the sum of all peptides of a single protein observed in
the mass spectrum. The threshold for inclusion in the list of
representative proteins was two or more SpC (i.e., peptides) for
each protein as average value in at least one of the three types of
samples.
The cellular distribution of the 293 representative proteins is
represented in Fig. 2 (for details refer to Supplementary Table 1;
Supplementary Data 1), showing that 34 proteins, detected by
∼60% of the number of SpC in all samples (7916 of 13,157 overall
number of SpC for representative proteins), were lysosomal
proteins. We can speculate that if all the protein classes were
equally represented in our samples, the 34 lysosomal proteins
among the 293 representative proteins (Supplementary Table 1)
would be represented by ∼1527 SpC and not by 7916 SpC, as we
observed. With this assumption, we estimate that the lysosomal
class is >5-fold enriched in our samples. This is a striking evidence
of lysosomal protein overrepresentation.
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An Euler diagram in Fig. 3 shows the distribution of the 293
representative proteins among different samples, as described in
Table 1. The ORG sample contains the highest number of proteins
and shares 80 proteins with the other two samples. TIS-NM and
ORG-NM, representing two different preparations of NM pigment,
contain fewer proteins. TIS-NM shares 68 proteins with ORG and
ORG-NM samples, while ORG-NM shares 89 proteins with ORG and
TIS-NM samples. A portion of representative proteins was uniquely
identiﬁed in each type of sample (94 proteins in ORG, 62 proteins
in TIS-NM, and 36 proteins in ORG-NM), but these were present in
very small quantities (<10 % of the overall number of SpC
detected for representative proteins); interestingly, 35 proteins
were commonly detected in all three samples, and these shared
proteins were present in high quantities (∼80 % of the overall
number of SpC detected for representative proteins; see data and
discussion in the legends of Fig. 3 and Table 1, and details in
following sections).
Proteins found in NM-containing organelles
The ORG samples were obtained directly from fresh SN tissue,
without freezing and after soft homogenization/centrifugation
procedures in order to preserve the original structure and
composition of these organelles. Transmission electron micro-
scopy conﬁrmed that the contents of the puriﬁed organelles were
mainly intact, with preserved lipid membranes and lipid bodies
that were morphologically identical to those observed in slices of
SN tissues. Importantly, low magniﬁcation images demonstrated
the absence of other cellular contaminants (Fig. 1d).
A group of 164 proteins was identiﬁed with SpC≥ 2 exclusively in
ORG sample (Table 1; Supplementary Data 1), while an additional
ten proteins were identiﬁed with SpC< 2 in ORG but detected with
SpC ≥ 2 in TIS-NM or ORG-NM samples. Then, we are considering
that the number of representative proteins in ORG sample is 174
(Table 1; Fig. 3; Supplementary Table 1).These data revealed that
ORG is characterized by a large group of lysosomal proteins (25
proteins, ~43% rel. # SpC), with far fewer proteins from other
organelles or cytosol (Fig. 2; Supplementary Table 1). In addition to
the set of soluble lysosomal proteins observed in all three types of
samples (proteases, esterases, sulfatases, glycosidases, hydrolases,
and other lysosomal proteins), here we identiﬁed typical lysosomal
membrane proteins including lysosome membrane protein 2
(SCARB2), CD63 antigen, type 1 phosphatidylinositol 4,5-bispho-
sphate 4-phosphatase (only in the ORG sample) and some functional
subunits of the lysosomal V-type proton ATPase (in ORG sample one
subunit as representative while other two subunits in very low
amounts and categorized as non-representative proteins), but not
lysosome-associated membrane glycoprotein 1 (LAMP1) or
lysosome-associated membrane glycoprotein 2 (LAMP2).
Due to the difﬁculties in preserving ORG membranes during
their isolation and related problems in LC-MS detection of
transmembrane proteins, we also performed WB and IEM
experiments to investigate lysosomal features of these organelles.
We conﬁrmed the presence of SCARB2 and V-type proton ATPase
subunit B, brain isoform (ATP6V1B2), a subunit of the lysosomal V-
type proton ATPase, in NM-containing organelles by WB on ORG
samples and by IEM in SN sections (Figs. 4 and 5; Supplementary
Fig. 2, 3). Likewise, both LAMP1 and LAMP2, while undetected by
LC-MS in ORG samples, were observed by WB and IEM (Figs. 4 and
5; Supplementary Fig. 2, 3).
Some non-lysosomal proteins were also detected, most of
which are classiﬁed as cytoskeletal and cytoplasmatic proteins. In
addition to typical tubulin chains (mainly beta chains), we found
tubulin polymerization-promoting protein, which is involved in
protein aggregation, inclusion bodies formation and neurodegen-
eration;30 we also detected heat shock protein HSP 90-alpha and
alpha-crystallin B chain, which has been reported as a component
of Lewy bodies and has been characterized as a chaperone.31
Additional cytoskeletal proteins included for example the
microtubule-associated protein tau and microtubule-associated
protein 6, which play roles in microtubule stability and are
implicated in neurodegenerative mechanisms.32,33
As a potentially important clue in PD pathogenesis,34,35 we also
detected alpha-synuclein (SNCA) exclusively in ORG samples. We
conﬁrmed this result by WB experiments on ORG samples and IEM
experiments on SN tissue slices, observing SNCA signals mainly in
the NM pigment and rarely in lipid bodies (Figs. 4 and 5).
We also found major histocompatibility complex, class I (HLA) in
ORG samples, consistent with our recent report of the ﬁrst
identiﬁcation of this protein in adult neurons.20 The identiﬁcation
of HLA was obtained by matching experimental spectra to peptide
sequences in speciﬁc databases for HLA (Supplementary Data 2).
Table 1. Summary of the proteomic analysis
ORG (n= 2) TIS-NM (n= 2) ORG-NM (n= 2) Overall
Number of proteins 563 407 220 1020
Number of SpC for all 1020 proteins 4229 7743 2023 13,995
Representative proteins (with SpC ≥ 2 as average value) 174 [164] 130 [116] 125 [101] 293
Number of SpC for the group of 293 representative proteins 3792 [3778] 7439 [7420] 1926 [1898] 13,157 [13,096]
Summary of proteomic analyses of different types of samples (ORG, TIS-NM and ORG-NM), calculated from Supplementary Data 1. Each type of sample was
prepared in duplicate and then analyzed by multiple LC-MS analyses. For details of subjects and preparation of samples for LC-MS analysis of proteins, see
Methods. The ﬁrst two rows show the number of proteins and their number of SpC for each kind of sample. Among the group of overall proteins detected in
these samples (1020 by 13,995 SpC), representative proteins were selected on the basis of their SpC, deﬁned as the sum of all peptides of a single protein
observed in the mass spectrum. We have classiﬁed a protein as representative in one type of sample, if detected by SpC ≥ 2 as average value. In the third row,
we report for each type of sample the following values: (i) in brackets, the number of proteins detected as representative (with SpC ≥ 2) uniquely in that type
of sample; (ii) without brackets, the number of representative proteins in that type of sample plus those identiﬁed as non-representative (with SpC < 2) in that
speciﬁc sample but listed as representative (with SpC ≥ 2) in at least one of the other type of samples (e.g., a protein that was detected as non-representative in
TIS-NM but as representative in ORG or ORG-NM samples would be included in the count for TIS-NM). The fourth row of the table shows the number of SpC
detected for the group of 293 representative proteins described in the third row, and in particular: (i) in brackets, the total number of SpC detected for
representative proteins (with SpC ≥ 2) uniquely found in that type of sample (e.g., 3778 is the number of SpC for 164 proteins uniquely detected in ORG
sample); (ii) without brackets, the total number of SpC of representative proteins plus the SpC of proteins identiﬁed as non-representative (with SpC < 2) in
that speciﬁc sample but listed as representative (with SpC ≥ 2) in at least one of the other type of samples (e.g., 7439 is the number of SpC for 130 proteins
detected in TIS-NM sample, including SpC of proteins uniquely found in TIS-NM plus those of proteins detected as non-representative in TIS-NM but as
representative in ORG or ORG-NM samples). The “Overall” column represents the overall number of proteins and peptides detected in all analyzed samples
(i.e., 293 is the number of all representative proteins detected in ORG, TIS-NM, and ORG-NM, considering only one time a protein present in two or more
samples)
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Fig. 2 Histogram of cellular distribution of the 293 representative proteins found in all analyzed samples shown as relative number of SpC vs.
cellular compartments. For details of subjects and preparation of samples for LC-MS analysis of proteins, see Methods. Some proteins may
have multiple cellular locations: for each protein the most typical and representative cellular location was assigned. The different types of
samples are represented by different colors (ORG, TIS-NM, and ORG-NM) and gray bars refer to overall representative proteins considered as a
single data set (indicated with “All Samples”). The “Rel. # SpC (%)” is the total number of SpC for a speciﬁc class of proteins (i.e., lysosomal)
referred to the overall number of SpC of representative proteins in each sample: this value represents the relative abundance of a particular
class of proteins in one sample (see also Supplementary Table 1). The term “Vesicles” refers to vesicle trafﬁcking, including proteins involved in
vesicular transport, fusion, etc. The category “Unknown cell location” consists of proteins for which a cellular location was still unclear, while
the class “Uncharacterized proteins” comprises proteins for which, at the moment of data analyses, a complete characterization and/or role
was missing
Fig. 1 Transmission electron microscopy images of NM-containing organelles in human SN tissue (a–c) and after the isolation procedure (d).
a–c SN tissue of 89 y.o. healthy subject. Intraneuronal NM-containing organelles of the SN are membrane bounded (black arrowhead in a and
b) and contain large amounts of NM pigment (black and electron dense), a protein matrix and lipid bodies (asterisk). Scale bar=1 µm in a.
Large lipid bodies (asterisk) are surrounded by a membrane as demonstrated in b (arrow), although the images do not distinguish between a
bilayer and single layer membrane. Considering that brain samples used in this study were post mortem tissues, it is striking that there is often
a double membrane around many of the organelles. At higher magniﬁcation, a double membrane delimiting NM-containing organelle is
clearly visible (empty arrowhead in c). d NM-containing organelles isolated from the SN tissue of 89 y.o. healthy subject (the same subject of
a–c). The purity and integrity of isolated NM-containing organelles is clearly demonstrated by transmission electron microscopy: low
magniﬁcation d demonstrates that cellular and subcellular debris are completely absent. The outer limiting membrane is not apparent, but
the constituents of the organelles appear intact with NM pigment, many lipid bodies (asterisks) and membranes of lipid bodies. Scale bar= 1
µm in d
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The presence of the antigen presenting protein HLA was
conﬁrmed with IEM on SN tissue, indicating a high accumulation
of HLA on NM granules of the SN (Supplementary Fig. 4).
Interestingly, some additional proteins identiﬁed only in ORG
sample were dynein heavy chain 12, axonemal and some ras-
related proteins (RAB8B, RAB14, and RAB33B as representative
proteins, while RAB2A, RAB5C, and RAB8A were present in low
amounts and categorized as non-representative), each of which
are involved in intracellular vesicle trafﬁcking.
Proteins found in NM pigment isolated from SN tissue
The TIS-NM samples were obtained from pooled SN tissues using
the puriﬁcation procedure adopted for previous chemical and
structural investigations on NM pigment.3,9,28 Despite the
chemical treatments (i.e., high-salt solutions, sodium dodecyl
sulfate, methanol, and hexane), repeated washings and proteinase
K digestions, proteomic analysis resulted in the identiﬁcation of
116 proteins with SpC ≥ 2 uniquely in TIS-NM (Table 1; Supple-
mentary Data 1). However, an additional 14 proteins with SpC < 2
in TIS-NM were found with SpC ≥ 2 in ORG or ORG-NM samples:
therefore, we estimate 130 to be the number of representative
proteins in TIS-NM sample (Table 1; Fig. 3; Supplementary Table 1).
The most highly represented and abundant class of proteins was
again lysosomal, even more so than in ORG samples. We detected
26 lysosomal proteins representing ~73% of rel. # SpC in this
sample (Fig. 2; Supplementary Table 1). Among these proteins,
high quantities of typical lysosomal enzymes were found, and
these were also identiﬁed in ORG and ORG-NM samples. However,
some lysosomal proteins were detected exclusively in TIS-NM
samples (e.g., epididymal secretory protein E1, fatty acid synthase,
cathepsin L1, lysosomal alpha-mannosidase, and ribonuclease T2).
Only one lysosomal membrane protein, the transmembrane
protein 106B, was identiﬁed exclusively in the TIS-NM sample.
Non-lysosomal proteins found in TIS-NM included ferritins,
mostly ferritin light chain (FTL) in contrast to ferritin heavy chain
(FTH1), heat shock protein HSP 90-alpha, and glyceraldehyde-3-
phosphate dehydrogenase. HLA was also detected in this sample
(Supplementary Data 2). By means of LC-MS analysis, we found
exclusively in this sample the mature chain of ATP synthase F(0)
complex subunit C3, mitochondrial (ATP5G3), the major storage
material accumulated in ceroid lipofuscinosis,36 as well as
cerebellin-2, the PD-associated protein DJ-1 and protein
disulﬁde-isomerase A3. Additionally superoxide dismutase
[Cu–Zn] was detected in TIS-NM and also as a fragment in ORG
sample. The ATP synthase F(0) complex subunit C1, mitochondrial
(ATP5G1) was also detected by WB in ORG samples; its presence
was also conﬁrmed by IEM, indicating that is localized in the NM-
containing organelles, where it is mainly bound to the NM
pigment. The antibody used in these experiments is expected to
recognize the three mature chains of proteins, namely ATP5G1,
ATP synthase F(0) complex subunit C2, mitochondrial (ATP5G2)
and ATP5G3, which are identical and encoded by three different
genes (Supplementary Fig. 2, 3).
Proteins found in NM pigment isolated from organelles
In order to study the protein matrix associated with the NM
pigment inside organelles and considering that aspeciﬁc proteins
might interact with NM during the isolation of TIS-NM from SN
tissues, we isolated NM pigment directly from ORG samples. The
amount of ORG-NM sample was lower than the other two types of
samples (ORG-NM < ORG < TIS-NM), as it was prepared from the
ORG sample; TIS-NM was isolated processing several SN pooled
tissues, while ORG and ORG-NM samples were prepared from one
or occasionally two SN tissues (Methods). This is clearly shown by
the number of SpC detected in each sample (Table 1). A group of
101 proteins was detected with SpC ≥ 2 exclusively in ORG-NM
(Table 1; Supplementary Data 1), while an additional 24 proteins
were identiﬁed in ORG-NM with SpC < 2 but detected with SpC ≥ 2
in ORG or TIS-NM samples. Therefore, we estimate the number of
representative proteins in ORG-NM sample to be 125 (Table 1; Fig.
3; Supplementary Table 1); the majority (89 proteins) were also
detected in ORG and TIS-NM samples (Fig. 3). Proteins identiﬁed
only in ORG-NM sample (36 proteins) were found in very low
amounts (<1 % rel. # SpC) (Fig. 3), thus indicating that almost no
contaminants affected the analysis of this type of sample.
As observed in ORG and TIS-NM, lysosomal proteins were also
prevalent in this sample (23 proteins; ~44 % rel. # SpC) (Fig. 2;
Supplementary Table 1). Moreover, lysosomal membrane proteins
(i.e., SCARB2 and CD63 antigen) and other cytoskeletal and
cytoplasmatic proteins (i.e., alpha-crystallin B chain, tubulin
polymerization-promoting protein, microtubule-associated pro-
tein tau, and low amounts of microtubule-associated protein 6)
found in ORG samples were observed in ORG-NM as well. Again,
LAMP2 was not detected in this sample by LC-MS, while LAMP1
was identiﬁed at very low levels and categorized as a non-
representative protein. These data suggest that thermal shock
treatments to purify NM pigment from organelles do not
completely disrupt the organelle. It is possible that some
Fig. 3 Area-proportional Euler diagram of the 293 representative
proteins (detected by SpC ≥ 2 as average value in at least one of the
three types of samples) identiﬁed in ORG, TIS-NM, or ORG-NM. For
details of subjects and preparation of samples for LC-MS analysis of
proteins, see Methods. The diagram was calculated using the
EulerAPE tool (Methods)138 and by using NCBI accession (GI
number). Outside the diagram we report for each type of sample
the following values: (i) in brackets, the number of proteins detected
as representative (with SpC ≥ 2) uniquely in that type of sample, as
reported in Table 1; (ii) without brackets, the number of
representative proteins plus those identiﬁed as non-representative
(with SpC < 2) in that speciﬁc sample but listed as representative
(with SpC ≥ 2) in at least one of the other type of samples (e.g., a
protein that was detected as non-representative in ORG sample but
as representative in TIS-NM would be included in the count for
ORG). Numbers in non-overlapping areas of circles report the
representative proteins found uniquely in that type of sample. The
overlapping areas correspond to proteins shared by two or three
different types of samples: e.g., a protein detected in all samples but
as representative only in ORG would be included in the overlapping
area of 35 proteins shared between ORG, TIS-NM, and ORG-NM.
Percentages in parentheses represent the ratio between the total
number of SpC of proteins belonging to one area of the diagram
and the overall number of SpC of representative proteins detected
in all samples. The highest percentage value is located in the area
shared between all three types of samples. The detailed list of
proteins is reported in Supplementary Data 1
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membrane portions are strongly connected to the contents of the
organelle and prevent the leakage of some proteins. Indeed,
membranous, cytoskeletal and cytoplasmic proteins were still
found in the analysis of ORG-NM sample. As observed in ORG and
in TIS-NM samples, HLA was also detected in this sample
(Supplementary Data 2).
Similarly, ORG-NM samples share several proteins with TIS-NM
(Fig. 3): e.g., the lysosomal prosaposin, heat shock protein HSP 90-
alpha (here detected in low amounts, but present as representa-
tive also in ORG and TIS-NM), glyceraldehyde-3-phosphate
dehydrogenase, some peptides of ferritins (again mostly FTL if
compared to FTH1), and the PD-associated protein ubiquitin
carboxyl-terminal hydrolase isozyme L1 (here as representative,
while in TIS-NM it was in low amounts and categorized as a non-
representative protein). ORG-NM and TIS-NM are analogous
samples since they are both isolated NM pigment. However, the
amount of ORG-NM sample is normally lower than that of TIS-NM,
while the ORG sample is the intact organelle containing the NM
pigment. Due to the identiﬁcation by LC-MS of FTL and FTH1 in
both ORG-NM and TIS-NM samples but not in ORG samples, IEM
and WB experiments were performed. IEM conﬁrmed the presence
of FTL and to a lesser extent FTH1 in NM-containing organelles of
the SN tissue. The accumulation of this iron-storage protein was
conﬁrmed by WB analyses that detected low levels of FTL but
failed to detect FTH1 in ORG samples (Supplementary Fig. 2, 3).
This may be due to chains of iron hydroxides that formed bridges
connecting NM and partially degraded ferritins, so that this
protein was bound to NM and was not present as a separate
molecule.
Examples of proteins identiﬁed as representative only in ORG-
NM include phospholipid hydroperoxide glutathione peroxidase,
mitochondrial, and lysosomal acid phosphatase.
Proteins detected in all three types of samples
A common group of proteins was identiﬁed in all types of
samples, corresponding to ~80 % of overall SpC detected for 293
representative proteins (Fig. 3; Table 2).
Within the set of lysosomal proteins detected in all three types
of samples (17 entries in Table 2), were peptidases (tripeptidyl-
peptidase 1, gamma-glutamyl hydrolase and lysosomal Pro-X
carboxypeptidase), proteases [cathepsin B, cathepsin Z and
cathepsin D (CTSD)], esterases (sialate O-acetylesterase and
palmitoyl-protein thioesterase 1), sulfatases (iduronate 2-sulfatase,
N-sulphoglucosamine sulphohydrolase, arylsulfatase B and N-
acetylgalactosamine-6-sulfatase), glycosidases (lysosomal alpha-
glucosidase), lipid hydrolases (acid ceramidase), and other
lysosomal proteins [mammalian ependymin-related protein 1
and putative phospholipase B-like 2 (PLBD2)]. CTSD, a classical
lysosomal marker, was detected in ORG samples by WB as heavy
chain mature form and was conﬁrmed by IEM as present
abundantly in the NM-containing organelles (Figs. 4 and 5). We
conﬁrmed by IEM and WB (Supplementary Fig. 2, 3) the presence
of the recently described PLBD2.37,38 In addition, we detected by
LC-MS phospholipase D3, apolipoprotein D (APOD), cerebellin-1,
transmembrane glycoprotein NMB (GPNMB), F-box only protein
11, heat shock protein HSP 90-alpha, and two ubiquitin-related
proteins, namely polyubiquitin-C (UBC) and ubiquitin-60S riboso-
mal protein L40 (UBA52). HLA peptides associated with NM were
identiﬁed by LC-MS analyses in all samples isolated from human
SN (Supplementary Data 2). In each type of sample we also found
protein phosphatase 1 regulatory subunit 1B, which potently
inhibits protein phosphatase-1.39 Moreover, various tubulins
(mainly beta chains) and other abundant proteins including glial
ﬁbrillary acidic protein, myelin basic protein, and creatine kinase B-
type were detected in all three samples (for other proteins see
Table 2; Supplementary Data 1). Due to the important roles of
APOD, GPNMB, ubiquitins, and HLA, we conducted IEM and WB
experiments, which conﬁrmed their localization inside the NM-
containing organelles (Figs. 4 and 5; Supplementary Fig. 4, 5, 6).
Relevant proteins not revealed by mass spectrometry but found
by other techniques
Additional IEM and WB studies were performed for some relevant
proteins not detected by LC-MS, probably due to instrumental
limitations and low abundance. Due to the lysosomal features of
the NM-containing organelle and its proposed autophagic origin,2
we performed WB and IEM experiments to verify the presence of
the autophagic marker microtubule-associated proteins 1A/1B
light chain 3B (MAP1LC3B), which was not detected by LC-MS like
in previous studies.23,24 Here, IEM experiments on SN tissues
revealed MAP1LC3B signals mainly engulfed inside NM-containing
organelles, on NM pigment, around lipid bodies and sometimes
lining their membranes (Fig. 4). In order to conﬁrm the presence of
this crucial protein, IEM experiments were also repeated using a
different antibody, conﬁrming the speciﬁc accumulation of
MAP1LC3B inside NM-containing organelles (Supplementary Fig.
4). In addition to IEM ﬁndings, WB analyses of ORG samples
demonstrated the presence of MAP1LC3B, thus conﬁrming the
autophagic nature of NM-containing organelle. Speciﬁcally, WB
analyses demonstrated mainly the MAP1LC3B-I form, while the
MAP1LC3B-II form was undetectable in ORG samples (Fig. 5).
Another important autophagy-related protein, the autophagic
adaptor sequestosome-1 (SQSTM1), was not detected by LC-MS
here and in previous studies,23,24 but was found by IEM and WB
analyses (Supplementary Fig. 5, 6).
Moreover, due to the presence of some Ras-related proteins, we
conﬁrmed the presence of Ras-related protein Rab-5A (RAB5A),
which is of interest due to its involvement in retrograde axonal
endosomal transport,40 by IEM and WB (Supplementary Fig. 5, 6)
but not by LC-MS.
Lipid bodies contain dolichols involved in NM synthesis and
typical membrane lipids
Within NM-containing organelles, electron micrographs demon-
strated the presence of membrane-bound lipid bodies, generally
ranging from 200 to 500 nm, sometimes reaching sizes as large as
1 µm, with some smaller lipid bodies (50–100 nm) entrapped in
the NM regions of the organelle (Fig. 1a–c). Conventional electron
microscopy on post mortem SN tissues does not clearly reveal if
these lipid bodies are surrounded by membranes formed of
normal bilayer or single layer.
LC-MS analyses of solvent extracts prepared from both TIS-NM
and ORG samples demonstrate that dolichols and dolichoic acids
were the major lipid components (Fig. 6). LC-MS analyses of both
solvent extracts further revealed the presence of signals
corresponding to different glycerophospholipids and sphingoli-
pids (Supplementary Table 2). Among sphingolipids, signals
attributable to sphingomyelin, neutral glycolipids (lactosylcera-
mide), sulfatides, and gangliosides (mono-, di-, and tri-sialogan-
gliosides) together with other lipid molecules such as free fatty
acids were identiﬁed (Supplementary Table 2). Thus, the lipid
bodies of ORG and the lipid mixtures adsorbed to TIS-NM contain
a wide variety of membrane amphipathic lipids, encompassing
both lipids typically enriched in neurons, such as gangliosides, and
lipids involved in oligodendrocyte function and myelin formation,
such as sphingomyelin and sulfatide.25,41 The proﬁle of amphi-
pathic lipids was not identical in TIS-NM and in ORG, in particular
as signals attributable to sulfatides were far higher in TIS-NM
(Supplementary Table 2), suggesting that some myelin lipids could
be adsorbed to TIS-NM during the puriﬁcation procedure. Indeed,
the presence of amphipathic lipids in the lipid bodies from ORG
and in lipid mixtures adsorbed to TIS-NM was conﬁrmed by TLC
analysis (Fig. 7). In the solvent extracts of the TIS-NM and ORG
samples, the amounts of dolichols and dolichoic acids were higher
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Table 2. Representative proteins commonly detected by LC-MS in all analyzed samples
NCBI accession (GI
number)
UniProt accession
number
Protein name Gene name Cellular location All samples
Total #
SpC
Average #
SpC
193785841 P61981 14-3-3 protein gamma YWHAG Cytoplasm 13 2
21536286 P12277 Creatine kinase B-type CKB Cytoplasm 41 6
4503979 P14136 Glial ﬁbrillary acidic protein GFAP Cytoplasm 124 14
21735492 Q9UD71 Protein phosphatase 1 regulatory
subunit 1B
PPP1R1B Cytoplasm 28 3
32526901 Q8WYA0 Intraﬂagellar transport protein 81
homolog
IFT81 Cytoskeleton 17 2
105990539 P07196 Neuroﬁlament light polypeptide NEFL Cytoskeleton 10 2
2119276 Q6LC01 Tubulin beta chain (fragment) N/A Cytoskeleton 126 11
4507729 Q13885 Tubulin beta-2A chain TUBB2A Cytoskeleton 22 3
21361322 P04350 Tubulin beta-4A chain TUBB4A Cytoskeleton 60 8
60729665 Q6Y288 Beta-1,3-glucosyltransferase B3GLCT Endoplasmic
reticulum
17 2
1575347 Q8IV08 Phospholipase D3 PLD3 Endoplasmic
reticulum
266 19
4502163 P05090 Apolipoprotein D APOD Extracellular 74 10
8247915 Q13510 Acid ceramidase ASAH1 Lysosome 225 17
825628 P15848 Arylsulfatase B ARSB Lysosome 53 4
4503139 P07858 Cathepsin B CTSB Lysosome 1058 63
3929733 Q6LAF9 Cathepsin B (fragment) N/A Lysosome 88 10
4503143 P07339 Cathepsin D CTSD Lysosome 343 24
22538442 Q9UBR2 Cathepsin Z CTSZ Lysosome 169 11
4503987 Q92820 Gamma-glutamyl hydrolase GGH Lysosome 1003 62
4557659 P22304 Iduronate 2-sulfatase IDS Lysosome 95 8
126590 P10253 Lysosomal alpha-glucosidase GAA Lysosome 37 3
4826940 P42785 Lysosomal Pro-X carboxypeptidase PRCP Lysosome 91 7
24475586 Q9UM22 Mammalian ependymin-related
protein 1
EPDR1 Lysosome 1489 88
4503899 P34059 N-acetylgalactosamine-6-sulfatase GALNS Lysosome 26 2
4506919 P51688 N-sulphoglucosamine
sulphohydrolase
SGSH Lysosome 47 4
4506031 P50897 Palmitoyl-protein thioesterase 1 PPT1 Lysosome 287 19
27734917 Q8NHP8 Putative phospholipase B-like 2 PLBD2 Lysosome 57 4
6808138 Q9HAT2 Sialate O-acetylesterase SIAE Lysosome 2043 124
2408232 O14773 Tripeptidyl-peptidase 1 TPP1 Lysosome 428 26
4505405 Q14956 Transmembrane glycoprotein NMB GPNMB Melanosome 49 11
68509930 P02686 Myelin basic protein MBP Membrane 1867 125
5912201 Q86XK2 F-box only protein 11 FBXO11 Nucleus 21 4
31542868 P13807 Glycogen [starch] synthase, muscle GYS1 Nucleus 6 1
4506645 P63173 60S ribosomal protein L38 RPL38 Ribosome 8 2
4757922 P23435 Cerebellin-1 CBLN1 Synapse 226 14
List of representative proteins commonly detected by LC-MS analyses in all samples. In the table for each protein, NCBI accession (GI number), UniProt
accession number, protein and gene name, cellular location, and few details of LC-MS analyses corresponding to all samples are reported. The column “All
Samples” refers to overall representative proteins commonly present in all three types of samples which are considered as a single data set. Note that some
proteins may have multiple cellular locations: for each protein the most typical and representative cellular location was assigned. A protein eligible to be
inserted in this list must be detected in all samples, and classiﬁed as representative (detected by SpC ≥ 2 as average value) in at least one of the three types of
samples. This list describes the 35 proteins contained in the central overlapping area of Euler diagram in Fig. 3. For full details see Supplementary Data 1. Two
ubiquitin-related proteins (UBC and UBA52) and heat shock protein HSP 90-alpha, although present in the three types of samples, were not included in the
group of proteins detected in all three types of samples (in this list and in the central overlapping area of Euler diagram in Fig. 3, containing 35 proteins)
because they were identiﬁed with different GI accession numbers in different samples. Note that the Euler diagram calculation was performed using NCBI
accession (GI number) only. Nevertheless, the above mentioned ubiquitin-related proteins and heat shock protein HSP 90-alpha, considered as unique
proteins, were detected in all three samples
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than other lipid molecules identiﬁed in both samples, as shown by
TLC analysis. In the lipid extracts from both samples, bands co-
migrating with sphingomyelin, phosphatidylcholine, lactosylcer-
amide, and phosphatidylethanolamine were identiﬁed. In addi-
tion, bands corresponding to galactosylceramide and sulfatide
(some of the typical myelin lipids)41 were clearly visible in the lipid
extracts from TIS-NM, particularly sulfatides as also conﬁrmed by
LC-MS, but not from ORG samples (Fig. 7). In the ORG sample,
there were comparable amounts of some sphingolipids (lacto-
sylceramide and sphingomyelin, a typical myelin lipid) and
glycerophospholipids (phosphatidylcholine and phosphatidy-
lethanolamine) (Fig. 7): since in membranes the sphingolipid
content is usually lower than that of glycerophospholipids, the
relative increase of sphingolipids vs. glycerophospholipids in ORG
likely indicates an inhibition of the lysosomal activity inside NM-
containing organelles. The presence of mono- and polysialogan-
gliosides was conﬁrmed by cholera toxin staining after sialidase
treatment of the aqueous phases obtained from TIS-NM, but not
from ORG, likely due to the paucity of the sample (Supplementary
Fig. 7). We note that in TIS-NM the membranes and any
component of organelles are removed after sodium dodecyl
sulfate treatment, but lipids and especially dolichols are still
adsorbed into NM structure, as shown after solvent (methanol and
hexane) extraction of NM and analysis of these lipids extracts by
LC-MS and TLC. The results indicate a selective afﬁnity of NM
pigment for some lipids, particularly dolichols and dolichoic acids,
as previously reported.3,9
Fig. 4 IEM of SN from healthy aged subjects for selected proteins. For number of IEM experiments, see Methods. CTSD (73 y.o.; gold particles
= 20 nm). LAMP2 (86 y.o.; gold particles= 20 nm). MAP1LC3B (69 y.o.; gold particles= 15 nm). SCARB2 (69 y.o.; gold particles= 15 nm). SNCA
(63 y.o.; gold particles= 15 nm). UBA52 (63 y.o.; gold particles= 15 nm). Lipid bodies are indicated by asterisks. NM pigment of the NM-
containing organelles appears as black and electron dense granular aggregates. Scale bar in each panel= 250 nm
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The LC-MS results indicate that a high level of dolichols at
different molecular weights (with 14–22 isoprene units) and their
oxidized derivatives such as dolichoic acids (with 14–21 isoprene
units) were present in TIS-NM samples, consistent with previous
LC-MS studies on lipids extracts from TIS-NM.3,42 This is probably a
consequence of membrane disruption during isolation of TIS-NM,
so that oxidized dolichols and dolichoic acids present in cytosol,
mitochondria and other organelles are released and then
adsorbed by NM pigment. However, the presence of dolichols
and dolichoic acids was also conﬁrmed by LC-MS in lipid extracts
from ORG samples, thus conﬁrming the speciﬁc accumulation of
this particular class of lipids inside the NM-containing organelles
(Fig. 6), mainly in their lipid bodies. Indeed, Fig. 1d shows an
electron microscopy image of NM-containing organelles isolated
from SN (ORG samples) with many lipid bodies. In addition, the
distribution of dolichols and dolichoic acids chain lengths in lipids
extracted from ORG samples was similar to that observed in TIS-
NM samples: 14–22 isoprene units for dolichols, and 14–21
isoprene units for dolichoic acids. This suggests that artifacts were
absent, as the same types of lipids were identiﬁed using two
different isolation procedures.
No known enzymes involved in dolichol metabolism were
observed in these organelles, suggesting that oxidation of
dolichols on the double bonds with formation of epoxides does
not occur inside NM-containing organelles. The conclusion that
dolichols are not synthesized within NM-containing organelles is
further supported by the absence of two key enzymes required for
dolichol synthesis, i.e., dehydrodolichyl diphosphate synthase
complex subunit DHDDS (DHDDS) and polyprenol reductase
(SRD5A3) which were not detected by LC-MS, WB, or IEM
(Supplementary Fig. 5, 6).
The presence of dolichols, dolichoic acids, and other lipids we
describe in the NM-containing organelle has never been reported
in previous studies. In the past, dolichols, dolichoic acids, and
other lipids were reported only in isolated NM pigment, a different
situation, as they can be adsorbed into NM during isolation and
originate from cytosol and other organelles that are broken during
the isolation process.28,42,43 Thus, in the present study we provide
the demonstration of the presence of these lipids in the lipid
bodies of intact NM-containing organelles.
DISCUSSION
Integrated methodology for NM samples preparations and the use
of different analytical methods
The study of protein and lipid pathways of NM-containing
organelles requires highly puriﬁed and well preserved organelles.
This is challenging because during their preparation, membrane
and soluble proteins can be lost and contamination of organelles
by proteins or lipids arising from other cellular compartments may
occur. Another factor is that human brain tissues used for
preparation of organelles are post mortem and thus affected by
degradation.44 The preparation of organelles can itself provide a
source of changes in the distribution of proteins and lipids, as
discussed in the ﬁrst paragraph of Results.
A previous report analyzed by LC-MS/MS the NM-containing
organelles isolated from SN tissues, but that isolation procedure
was different than that used here and started from frozen
tissues.23 It is well known that freezing and thawing of post
mortem tissues can break the membranes, with leakage of
proteins that can diffuse among organelles as a possible source
of contamination. A later study proposed a new centrifugation
method for the combined isolation and enrichment of NM
granules (i.e., NM-containing organelles) and synaptosomes from
human SN for proteomic analysis, but again this method
processed frozen tissues.45 More recently, the same group
performed a proteomic analysis on NM-containing organelles
obtained by laser capture microdissection from human SN frozen
slices.24 The clear advantage of this new methodology is in
isolating NM-containing samples from very low quantities of
tissues, but the laser capture microdissection lacks sufﬁcient
Fig. 5 WB (for proteins detected by IEM in Fig. 4) performed on SN
tissue lysates and on ORG samples. For number of WB analyses, see
Methods. CTSD (protein content ratio SN tissue lysate/ORG= 3.1).
The band present in both SN tissue lysate (16 pooled tissues, from
48 to 85 years of age) and ORG sample (isolated from one subject,
81 y.o.) corresponds to the mature CTSD heavy chain which is highly
enriched in ORG sample, considering that the total protein content
in ORG was 3.1-fold lower than that of SN tissue lysate. LAMP2
(protein content ratio SN tissue lysate/ORG= 1.0). LAMP2 protein
was lightly present in ORG sample (isolated from one subject, 83 y.
o.), while in SN tissue lysate (13 pooled tissues, from 62 to 86 years of
age) this protein is largely expressed. The antibody used here
recognizes all three LAMP2 isoforms. MAP1LC3B (protein content
ratio SN tissue lysate/ORG= 1.8). The black arrowhead indicates the
MAP1LC3B-I form, which was more prevalent in SN tissue lysate (ﬁve
pooled tissues, from 73 to 85 years of age) than the MAP1LC3B-II
form (empty arrowhead indicating the phosphatidylethanolamine
conjugated form). In ORG sample (isolated from one subject, 77 y.o.),
the MAP1LC3B-I form was abundant while MAP1LC3B-II form was
undetectable. SCARB2 (protein content ratio SN tissue lysate/ORG=
2.3). Here we note an enrichment of SCARB2 in ORG sample
(isolated from one subject, 77 y.o.) if compared to SN tissue lysate
(ﬁve pooled tissues, from 73 to 85 years of age), considering that the
total protein content in ORG was 2.3-fold lower than that of SN
tissue lysate. SNCA (protein content ratio SN tissue lysate/ORG=
3.4). The black arrowhead indicates the soluble-monomeric form of
SNCA which is clearly visible in SN tissue lysate (nine pooled tissues,
from 67 to 85 years of age) while undetectable in ORG sample
(isolated from one subject, 66 y.o.). Other bands at higher molecular
weight are present in SN tissue lysate, corresponding to ﬁbrils and
aggregates with possible modiﬁcations. In the ORG sample, two
main bands are clearly visible corresponding to some aggregated/
modiﬁed forms of SNCA (at ~50 and ~58 kDa) which are present also
in SN tissue lysate. UBA52 (protein content ratio SN tissue lysate/
ORG= 2.7). The black arrowhead indicates the free ubiquitin that is
scarcely visible in SN tissue lysate (eight pooled tissues, from 62 to 89
years of age), but abundant in the ORG sample (isolated from one
subject, 66 y.o.). The WB also reveals the presence of large number of
immunoreactive high molecular weight bands corresponding to
high amounts of poly-ubiquitinated proteins, both in SN tissue lysate
and highly enriched in the ORG sample, although the total protein
content in ORG was 2.7-fold lower than that of SN tissue lysate
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resolution to discern among different subcellular components that
are clearly present among NM-containing organelles of the tissue
(Fig. 1a–c and see previous ﬁndings)1,3,9,10 and therefore can
represent a source of contamination. With such a procedure, the
collected samples inevitably would contain different types of
debris deriving from other cellular components.
Additionally, the LC-MS/MS employed here for proteomic
analysis provides a multidimensional protein identiﬁcation
technology method, which is an excellent gel-free approach and
provides improved selectivity and resolution of peptide separa-
tion, with an increased number of identiﬁed proteins and better
quantitative determinations in complex mixtures.46 In order to
improve the identiﬁcation of protein and lipid pathways, and to
distinguish proteins and lipids related to different components of
the NM-containing organelle, we analyzed three different NM
preparations (ORG, TIS-NM, and ORG-NM): the NM-containing
Fig. 6 LC-MS analysis of lipids isolated from TIS-NM and ORG samples. The TIS-NM sample here represented was isolated from a pool of seven
subjects (from 71 to 85 years of age), while the ORG sample was isolated from two pooled subjects (74 and 89 y.o.). Mass spectra (averaged
mass spectra, range 1200–1500m/z) demonstrate the presence of dolichols species in both samples. We highlight the series of singly charged
ions with different chain lengths, corresponding to dolichols with terminal hydroxyl group, their oxidized derivative dolichoic acids, and
acetate adducts of dolichols species. Both spectra selectively show dolichol species with chain lengths ranging from 17 to 21 isoprene units,
although few dolichol species with lower and higher number of isoprene units were found in lipid extracts from both samples (Results).
Abbreviations used in the ﬁgure: Dol, dolichol; Dol-Ac, dolichol acetate; Dol-CA, dolichoic acid
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organelles isolated from SN, NM pigment isolated from SN tissues,
and NM pigment isolated from NM-containing organelles. The
localization of some proteins in NM-containing organelles and
other cellular organelles was also conﬁrmed by IEM in intact SN
tissue slices.
Notably, in the present study, fresh (rather than frozen and
thawed) SN tissue was examined and the isolation procedure
enabled us to obtain highly puriﬁed NM-containing organelles
with well preserved membranes and lipid bodies, as demon-
strated in electron micrographs (Fig. 1c). The only contaminant
rarely observed in ORG preparations were a few red blood cells,
and so their associated previously identiﬁed proteins47,48 were
subtracted from the proteomic data sets of ORG samples
(Methods).
It is noteworthy that the larger mass of our samples in any of
the three types of preparations contained the same 35 proteins
(corresponding to ∼80 % of the overall SpC of representative
proteins detected in all samples, as shown in Fig. 3), thus
demonstrating the high reproducibility and pertinence of the
detected proteins in the NM-containing organelle.
Euler diagrams (Supplementary Fig. 8) show the comparison of
our proteomic data with those previously reported by Tribl et al.
and Plum et al.23,24 Considering all the proteins here identiﬁed
(Supplementary Fig. 8a), there are 50 proteins found also within
the 72 proteins (∼69 %) identiﬁed by Tribl and colleagues.23
Among these overlapping proteins, we observed that 36, 32, and
34 proteins belong to ORG, TIS-NM, and ORG-NM respectively,
representing ∼6 %, ∼8 %, and ∼15 % of all proteins detected in
each of the three types of samples (Supplementary Data 1; Table
1). The observation that NM-containing organelles analyzed in the
mentioned study23 had the highest similarity with our NM
pigment isolated from organelles (ORG-NM) suggests that samples
in that study featured broken membranes and contained mainly
proteins strictly bound to NM pigment. In the present study, we
isolated the NM pigment from its organelle by intentionally
breaking membranes with a freeze/thaw procedure, while Tribl
and colleagues isolated the NM-containing organelles from SN
frozen tissues.
In parallel, the comparison between the list of all the proteins
we identiﬁed and the list of 1000 proteins reported by Plum and
colleagues24 shows that 188 proteins (∼19 % of proteins identiﬁed
by Plum’s group) are shared by the two studies (Supplementary
Fig. 8a). A more detailed analysis of the overlapping proteins
shows that 102, 99, and 71 proteins belong to ORG, TIS-NM, and
ORG-NM respectively, representing the ∼18 %, ∼24 %, and ∼32 %
of all proteins detected in each of the three types of samples
(Supplementary Data 1; Table 1). Also in this case, the ORG-NM
sample shows the highest similarity with the samples analyzed by
Plum et al. (Supplementary Data 1).
Among new proteins related to NM-containing organelles
detected by LC-MS, here we report some lysosomal proteins that
were not found in the two previous studies: e.g., iduronate 2-
sulfatase, carboxypeptidase Q, lysosomal acid phosphatase,
lysosomal alpha-mannosidase, and ribonuclease T2. In addition,
we reported many other proteins of noticeable interest among
those never identiﬁed before as associated with NM-containing
organelles: examples include HLA, GPNMB, transmembrane
protein 106B, F-box only protein 11, protein phosphatase 1
regulatory subunit 1B, intraﬂagellar transport protein 81 homolog,
etc. (Supplementary Data 1). Some of these proteins have been
independently conﬁrmed by IEM and/or WB as discussed below.
Finally, it should be noted that there are 43 proteins shared by
our study and other two studies,23,24 considering all the proteins
we detected (Supplementary Fig. 8a; Supplementary Data 1). If we
evaluate the most enriched proteins detected in all the studies by
using different samples and methodologies, we should overlap
our representative proteins with the 166 signiﬁcantly over-
represented proteins reported by Plum’s group and with those
detected by Tribl et al. The result of this evaluation is a small
group of 18 proteins (Supplementary Fig. 8b), 16 of which are
lysosomal proteins. If we exclude these 16 typical lysosomal
proteins, there are two particularly interesting proteins detected in
all three studies. These two proteins, both primarily assigned to
endoplasmic reticulum, are phospholipase D3 and protein
disulﬁde-isomerase A3, which seem to be closely related to NM-
containing organelles and are brieﬂy discussed below.
The NM-containing organelle is an autophagic lysosome with
particular catabolic features
Protein analyses of the three different types of NM-derived
samples (ORG, TIS-NM, and ORG-NM) revealed that lysosomal
Fig. 7 High performance TLC analysis of total lipid extracts obtained
from TIS-NM and ORG samples. The TIS-NM sample here repre-
sented was isolated from a pool of four subjects (from 62 to 86 years
of age), while lipids of from three ORG samples (each isolated from
three different subjects, respectively 62, 61 and 77 y.o.) were pooled
before loading onto the TLC plates. After separation, lipids were
detected by spraying the TLC plate with anisaldehyde. In TIS-NM
sample the intense spot at the solvent front likely corresponds to
dolichols and dolichoic acids, as conﬁrmed by LC-MS (Fig. 6). The
content of sphingomyelin, galactosylceramide, sulfatides (typical
myelin lipids), and lactosylceramide is higher than phosphatidy-
lethanolamine and phosphatidylcholine (glycerophospholipids). In
the ORG samples, the main components are again dolichols and
dolichoic acids at the solvent front. In this sample there are
comparable amounts of sphingolipids (lactosylceramide and sphin-
gomyelin) and glycerophospholipids. The arrows at the margin of
the image indicate the position of pure standard lipids co-
chromatographed with the samples, as described in Methods.
Abbreviations used in the ﬁgure: GalCer, galactosylceramide; GD1a,
GD1b, GM1, GT1b, gangliosides GD1a, GD1b, GM1, GT1b; GlcCer,
glucosylceramide; LacCer, lactosylceramide; PC, phosphatidylcho-
line; PE, phosphatidylethanolamine; SM, sphingomyelin; ST,
sulfatides
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proteins are the major class of proteins in the NM-containing
organelle, representing ~60% of overall representative peptides
identiﬁed in all samples (Fig. 2; Supplementary Table 1).
Comparison of our data with recent lists of deﬁned human
lysosomal proteins38,49,50 indicates good overlap but also some
differences in the distribution of lysosomal enzymatic classes. In
particular, the Euler diagrams (Supplementary Fig. 9) and
additional table (Supplementary Data 3) show the comparison
between our data and the study by Sleat and colleagues,38 which
is the most detailed human brain proteomic study performed by
detecting only the soluble resident lysosomal proteins using
mannose 6-phosphate (Man-6-P) as an univocal lysosomal marker.
Among all the proteins here identiﬁed (Supplementary Fig. 9a), we
found 26 of the 48 (∼54 %) conﬁrmed lysosomal soluble proteins
of human brain;38 if we consider our representative proteins only,
we found 22 of 48 (∼46 %) conﬁrmed lysosomal proteins
(Supplementary Fig. 9b).
It thus appears that peptidases and a majority of esterases are
overrepresented in our samples, while lipases and glycosylases are
underrepresented (Supplementary Data 3). In detail, 10 of 14
peptidases (E.C. 3.4.-) belonging to human brain lysosomes38 were
detected and in large amounts in our samples (with overall 3243
SpC, corresponding to ∼41% of lysosomal SpC), suggesting again
an overrepresented complement of protein degradation pathways
in NM-containing organelles (see also ﬁrst paragraph of Results).
The identiﬁcation of CTSD in its heavy chain (mature form) as
abundant in all samples, revealed by LC-MS data and conﬁrmed
by WB and high IEM gold signals, is notable considering its role in
limiting lysosomal storage diseases51 and in inhibiting SNCA
aggregation.52 Similarly, 6 of 11 lysosomal esterases (E.C. 3.1.-)
identiﬁed in human brain lysosomes38 were detected by overall
2523 SpC, corresponding to ∼32 % of lysosomal SpC (Supplemen-
tary Data 3). Among these proteins, sialate O-acetylesterase, a key
enzyme involved in sialic acid catabolism, was the lysosomal
esterase we detected by the highest number of peptides (i.e.,
overall 2043 SpC).
In contrast, typical lysosomal human brain enzymes mainly
involved in lipids, phospholipids, and sphingolipids catabolism,
including lysosomal acid lipase, group XV phospholipase A2, and
sphingomyelin phosphodiesterase were not detected. We
observed only elevated quantities of PLBD2 and phospholipase
D3, two poorly characterized proteins of unknown functions, that
were identiﬁed both as potential proteins of human brain
lysosomes38 and in previous studies on NM-containing orga-
nelles.23,24 PLBD2, also conﬁrmed and localized by IEM signals, is a
new putative lipase37,38 with uncertain enzymatic activity, with the
exception of a homolog protein in amoeba that cleaves acyl
chains of some phospholipids (phosphatidylinositol, phosphatidy-
lethanolamine, and phosphatidylcholine).53 Due to the accumula-
tion of dolichols in NM-containing organelles, and considering
that dolichols may be transported to lysosomes as dolichyl esters
and then hydrolyzed by an unknown dolichyl esterase,54 we
attempted to test by molecular docking if dolichyl esters are
possible substrate of PLBD2, but obtained no ﬁt (not shown).
Similarly, despite its classiﬁcation as an esterase, neither a deﬁnite
enzymatic activity nor speciﬁc substrates have been clearly
reported for phospholipase D3.55,56 Nevertheless, phospholipase
D3 is abundantly expressed in brain and neural tissues,55,56 is
correlated with the modulation of cellular resistance to oxidative
stress57 and has been recently indicated as a key factor in the
pathological processes of Alzheimer’s disease.58 The ﬁnding of
large amounts of both of these two recently discovered enzymes
in all samples indicates a need for further investigation into their
roles in NM-containing organelles and lysosomes, in particular on
metabolism and storage of lipids.
Another group of less represented enzymes are glycosylases:
indeed, only 5 of at least 14 enzymes classiﬁed as glycosylases and
reported by Sleat and colleagues (Supplementary Data 3),
principally involved in glycoproteins, glycosaminoglycans and
glycosphingolipids degradation pathways in lysosomes,59,60 were
detected and in very low amounts (overall 49 SpC, <1 % of
lysosomal SpC). Concerning the shortage of enzymes related to
catabolic pathways of lipids in our samples, an exception is acid
ceramidase and its speciﬁc prosaposin (which undergoes proteo-
lytic cleavage to form saposins), both involved in the last step of
sphingolipids degradation pathway in lysosomes.60 Acid cerami-
dase and prosaposin were found in NM-containing organelles by
relative high amount of peptides (overall 225 SpC and 70 SpC,
respectively).
Thus, it appears that NM-containing organelles possess a low
representation of typical components of phospholipids and
sphingolipids degradation pathways. This could indicate that
NM-containing organelles lose the ability to conduct speciﬁc
enzymatic pathways as it accumulates in neurons, and could be
related to the particular lipid storage content of NM-containing
organelles, consisting mainly of dolichols,3,42 for which catabolic
pathways are still unclear and unrelated to phospholipid/
sphingolipid pathways. On the other hand, our ﬁndings are
consistent with the presence of undegraded glycerophospholipids
and sphingolipids in the lipid extract from the lipid bodies.
Lysosomal membrane proteins are less represented in NM-
containing organelles than conventional lysosomes
Among lysosomal membrane proteins, we detected by different
techniques SCARB2, LAMP1, LAMP2, CD63 antigen, type 1
phosphatidylinositol 4,5-bisphosphate 4-phosphatase, and some
V-type proton ATPase subunits. In particular, SCARB2 was shown
by LC-MS, IEM and WB to be the most abundant lysosomal
membrane protein in NM-containing organelles. One function of
SCARB2 may be to transport β-glucocerebrosidase into the
lysosome,61 although as above β-glucocerebrosidase was not
identiﬁed in this study by LC-MS. SCARB2 also belongs to the
scavenger receptor class B family involved in the transport of high
density and low density lipoproteins, cholesterol esters, phospho-
lipids and oxidized phospholipids,62,63 and if overexpressed,
induces endosomes/lysosomes enlargement and cholesterol
accumulation in the enlarged compartments.64 The abundance
of dolichols into the NM-containing organelles could be related to
the presence of high amounts of SCARB2 in NM-containing
organelles. This protein is present both on the organelle
membrane and its lumen, especially in lipid bodies and sometimes
in NM pigment, and is apparently accumulated in the NM-
containing organelle during aging (see below).
Other lysosomal membrane components were identiﬁed to a
lesser extent, including LAMP1, LAMP2, CD63 antigen, type 1
phosphatidylinositol 4,5-bisphosphate 4-phosphatase, and some
subunits of V-type proton ATPase. Considering the probable
partial loss of membranes during isolation procedures and/or due
to problems in detecting membrane proteins by LC-MS, IEM and
WB analyses were performed, which demonstrated the presence
of LAMP1, LAMP2, and ATP6V1B2 subunits, mainly in the luminal
portion of the NM-containing organelles. The antibody used for
LAMP2 detection by IEM and WB recognizes all three LAMP2
isoforms, and so we cannot distinguish between LAMP2A (the
chaperone-mediated autophagy receptor), LAMP2B (probably
involved in macroautophagy), and LAMP2C.65 Autophagosomes
possess LAMP2B and LAMP2C isoforms, which have uncertain
functions distinct from chaperone-mediated autophagy.66 How-
ever, LAMP2 appears to have a low presence with abnormal
location in the NM-containing organelle, which could be
consistent with the age-related decreased level of this protein,
particularly for LAMP2A in lysosomes,67 as well as a general
decline of autophagic-lysosomal function that occurs in normal
aging. These observations suggest that NM-containing organelles
are likely derived from macroautophagic organelles (see next
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paragraph), rather than lysosomes specialized for chaperone-
mediated autophagy.
The identiﬁcation by LC-MS of only low levels of V-type proton
ATPase functional subunits, responsible for acidiﬁcation of
lysosomes, may indicate a decreased acidiﬁcation and diminished
lysosomal catabolism. As vacuole fusion requires an electroche-
mical membrane potential created by the V-type proton ATPase,
NM-containing organelles may have a low capacity for fusion with
lysosomes or autophagosomes. IEM experiments revealed that
ATP6V1B2 subunit is not evident on the membrane of NM-
containing organelles (in contrast to lysosomes) but is sparsely
located in NM pigment and lipid bodies, conﬁrming a likely
functional deﬁciency of V-type proton ATPase in the NM-
containing organelles.
The NM-containing organelle originates from macroautophagy
and accumulates MAP1LC3B
Little is known about the origin of the NM-containing organelle.
Experiments in cultured neurons showed that an excess of
cytosolic DA induces NM synthesis and NM-containing organelles
formation, and the induced pigment was chemically identical to
human NM as assessed by electron paramagnetic resonance.2,10 In
addition, the identiﬁcation of a double membrane around these
induced organelles of NM and surrounding NM-containing
organelles of the human SN, as previously reported2,10 and here
conﬁrmed (Fig. 1c), together with presence of many lysosomal
hydrolases, suggests that the NM-containing organelle is a
pigmented autophagic vacuole.2
We have shown in previous studies electron microscopy images
of NM-containing organelles of human brain that have a clearly
different ultrastructural appearance than lipofuscin and lyso-
somes.2,3,9,10 Another paper described the species-speciﬁc ultra-
structure of neuronal lipofuscin by electron microscopy, thus
showing morphological features of lipofuscins that are quite
different from that of NM-containing organelles.68
Here we report the presence of the macroautophagy marker
MAP1LC3B inside NM-containing organelles, conﬁrming its
autophagic nature. Using IEM on SN tissues, we found MAP1LC3B
localized around lipid bodies, lining membranes and remarkably
on NM pigment within organelles. This evidence conﬁrms that
NM-containing organelles may derive by formation of MAP1LC3B-
positive autophagosomes that engulf forming NM and related
proteins and lipids components present in the cytosol, and
successively fuse with lysosomes, forming NM-containing auto-
lysosomes that become NM-containing organelles (Fig. 8).
The level of MAP1LC3B-II is thought to be a reliable indicator of
autophagosome formation.69 However, in our ORG samples, the
MAP1LC3B-II form was undetectable by WB compared to
MAP1LC3B-I, either because it was delivered at low levels or
because it was normally degraded by lysosomal enzymes. It is
likely that MAP1LC3B-II form could be degraded by the lysosomal
hydrolases we found, as normally occurs after the fusion of our
special autophagosomes with lysosomes (Fig. 8), and therefore
this transient supply of lysosomal enzymes would degrade some
substrates. Indeed, after autophagosome fusion with lysosomes to
form autolysosomes, intra-autolysosomal MAP1LC3B-II is normally
degraded by lysosomal hydrolases and is difﬁcult to detect.70
The NM-containing organelle is an aged and impaired lysosomal-
related organelle that accumulates proteins, indigestible NM, and
dolichols
In addition to acid ceramidase, other proteins (as previously
described) including tripeptidyl-peptidase 1 and APOD were
present in high amounts in the samples and have been also
reported as major components of lipofuscin-like lysosomal
inclusion bodies.71 APOD is involved in binding and transport of
lipids,72 in their protection from oxidation and consequent
oxidative stress.73 APOD is consistently upregulated and highly
expressed during normal aging,74 in overall SN tissue of PD
patients75 and other neurodegenerative diseases,72 where oxida-
tive stress and lipid abnormalities are implicated. As mentioned,
SCARB2 accumulates in the NM-containing organelle as also
reported for lysosomal inclusion bodies.71 While SCARB2 is a
protein of the lysosomal membrane, it was also found on the
luminal side of the NM-containing organelle particularly in lipid
bodies and sometimes in NM pigment. Although some of these
proteins may be enriched in the NM-containing organelle due to
their particular role or because they are normally overexpressed
during aging, these proteins may be also accumulated due to
impaired degradation in NM-containing organelles.
We note that ATP5G1/2/3, that we found in NM-containing
organelles, is the primary marker of broad range of neuronal
ceroid lipofuscinoses (i.e., CLN2, -3, -4, -5, -6, -7, -8, -9, CLCN7).36
ATP5G1/2/3 accumulates in autophagic vacuoles and lysosomes of
neurons where autophagy or some lysosomal enzymes are
blocked, as in lysosomal storage disorders.76,77 Intriguingly, this
protein also accumulates inside autophagic vacuoles in normal
aged mice,76 consistent with a decline of autophagic-lysosomal
function during normal aging. Similar to the age-dependent
accumulation of dolichols in brains of the elderly,78,79 which was
greatly increased in patients with neuronal ceroid lipofuscino-
sis,80,81 ATP5G1/2/3 accumulates in lipofuscin-like lipopigments
inside normal neurons during aging, a process ampliﬁed in
neuronal ceroid lipofuscinosis and other lysosomal disorders.82
Interestingly, these previously reported observations are consis-
tent with the LC-MS detection of this protein speciﬁcally in TIS-NM
samples, which can be associated to the early stages of NM-
containing organelle formation. Additionally, saposins, which were
detected in our samples in the form of prosaposin, have been
identiﬁed as the main storage material (particularly saposins A and
D) in two types of neuronal ceroid lipofuscinosis, CLN1 and
CLN10.36
Other proteins accumulated inside NM-containing organelles
are cerebellin-1 and cerebellin-2, which have unknown functions.
Cerebellin-1 (which we found in all analyzed samples) is
preferentially expressed in cerebellar synapses, where it is
required for synapse integrity and plasticity, but is also present
at variable concentrations elsewhere in the brain, and a study
reports its presence in the endo-lysosomal compartments of
neurons.83 Cerebellin-1 is more highly expressed in SN (A9)
neurons than ventral tegmental area (A10) neurons of mice,84
suggesting a mechanism for its accumulation similar to that of NM
in dopaminergic neurons of SN, and is also highly expressed in
mucopolysaccharidosis type IIIB mouse brains.85
Previous studies have suggested the storage features of the
NM-containing organelle: (i) indigestible NM pigment increases in
concentration in neurons from very early life over the entire life
span;3–6 (ii) NM pigment binds high quantities of dolichols;3,9,42,43
and (iii) NM pigment accumulates large amount of endogenous
and environmental metals.3,15 We now report the identiﬁcation of
storage material in these aged organelles, suggesting that
mechanisms for degrading protein and lipid components are
impaired, despite the presence of several enzymes inside NM-
containing organelles. This evidence, together with low levels of
some catabolic lysosomal enzymes and shortage of lysosomal
membrane proteins (as discussed in the previous sections on
lysosomal proteins), including V-type proton pump ATPases
involved in acidiﬁcation, suggests that the NM-containing
organelle is an aged impaired lysosomal-related organelle unable
to completely digest its content.
This organelle, due to its particular content of undegradable NM
pigment, proteins, lipids and metals (see below), could be also a
source of oxidative stress (Fig. 8). Therefore, the presence of
proteins involved in protection against oxidative stress are
notable: i.e., phospholipid hydroperoxide glutathione peroxidase,
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protein DJ-1, superoxide dismutase [Cu–Zn], and APOD. Here, we
brieﬂy highlight two examples. Phospholipid hydroperoxide
glutathione peroxidase, which contributes to redox balance in
cells, protects lipid membranes from oxidation and was previously
observed to co-localize with NM pigment of dopaminergic SN
neurons. Indeed, this hydroperoxidase was signiﬁcantly reduced in
overall parkinsonian SN compared to controls, but was increased
in the surviving SN neurons.86 Protein DJ-1 has been identiﬁed as
an atypical peroxidase that scavenges hydrogen peroxide derived
toxicity87 and mutations in its gene are associated with early-onset
PD.88
We investigated FTH1 and FTL, proteins involved in iron
homeostasis/storage, in NM-containing organelles. Using immu-
nohistochemistry, we previously reported that FTH1 and FTL
content in NM-containing neurons of SN is much lower than that
of neurons not containing NM or glia. Oligodendrocytes showed
the highest positive reactions for both FTL and FTH1, while in
neurons enriched with NM-containing organelles the staining for
FTH1 and FTL was generally undetectable with this technique.5,6
Due to technical limitations of peroxidase immunohistochemistry,
low quantities of these iron storage proteins could not be
revealed. By using techniques with high sensitivity (LC-MS and
IEM), we now conﬁrm the presence of FTL previously reported89
and, to a lesser extent, of FTH1 in NM-containing organelles of the
SN. In conclusion there are low levels of ferritins inside NM-
containing organelles, while the abundant NM pigment is the
major iron storage complex of pigmented neurons.3,5,6,14
The presence of HLA in NM-containing organelles and its
accumulation in NM pigment may have important consequences
for preferential vulnerability of catecholaminergic pigmented
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Fig. 8 Hypothesized scheme summarizing NM-containing organelle formation in human SN. a, b In the cytosol of SN neurons, DA can be
oxidized to semiquinones and quinones via iron catalysis, and these highly reactive compounds can react with aggregated and β-structured
proteins that accumulate in the cytosol. c The oxidative polymerization of quinones initiates with the formation of the melanin-protein
complex which can also bind high levels of metals, especially iron. During this step drugs and toxicants can also bind to the melanin-protein
complex.18 Proteins damaged by misfolding and DA-adducts formation may be recognized and bound by ubiquitins (green) and alpha-
crystallin B chain, in the attempt to degrade damaged and/or misfolded proteins in the proteasome pathway. It may be that ubiquitinated-
NM-derived products are too large and damaged to be degraded by the proteasome system.91 d, e The resulting undegradable material
accumulates in the cytosol. GPNMB and tubulin polymerization-promoting protein could be engaged at this step, since these proteins are
involved in the formation of aggresome-like structure and degradation of cellular debris.105,110 The accumulated undegradable material is
then taken up into autophagic vacuoles by the phagophore, an isolation double membrane which engulfs bulk material for macroautophagy.
This is conﬁrmed by the presence of some typical macroautophagic markers94 such as MAP1LC3B (red) and SQSTM1 (orange), and by the
presence of a double membrane surrounding the NM-containing organelle as displayed by electron microscopy (Fig. 1c). f These autophagic
vacuoles fuse with lysosomes, shown in the scheme with numerous enzymes (black), different membrane proteins (blue) and the proton
pumps (violet), to become autolysosomes containing the enzymes, proteins and lipids of lysosomes. After fusion with lysosomes, the
undegraded and NM-derived material contained in the autophagic vacuoles can interact with other lipids and other proteins carried by
lysosomes. A decreased lysosomal enzyme efﬁciency and reduced fusion capacity could occur also as a consequence of aging, oxidative stress
and NM accumulation. g These organelles can fuse with other vesicles or with other autophagic vacuoles containing NM precursors or with
old NM-containing organelles, etc. This fusion could lead to the accumulation in the lumen of the organelle of membranous portions which
would otherwise be degraded, while dolichols in particular are not chemically decomposed and accumulate with other undegraded lipids
leading to the formation of lipid bodies. Dolichols (or dolichyl esters) may be transported into the organelle by vesicle transport and
membrane fusion. Fusion of organelles could be mediated by RAB5A, tubulin polymerization-promoting protein, microtubule-associated
protein tau and other related proteins. This aged organelle, due to its particular content of undegradable NM pigment together with
damaged and oxidized proteins, lipids and metals, is a reservoir of buffered toxins (red stars). Under conditions of cellular damage these toxins
together with NM pigment could be released and induce neuroinﬂammation and neurodegeneration.19 h The ﬁnal NM-containing organelle
is the result of a complex and continuous process occurring during aging, that leads to the accumulation of undegradable material in
specialized pigmented “autophagic lysosomes”. Figure modiﬁed from previously published papers, by permission of Springer13 and by
permission of Elsevier14
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neurons in SN and locus coeruleus of PD patients. HLA expression
is higher in SN and locus coeruleus pigmented neurons than other
brain neurons, and SN dopaminergic neurons in culture can
express HLA that can bind peptides from endogenous or
exogenous proteins and present them on neuronal membrane
leading to targeting by CD8+ lymphocytes and death.20,90
Proteins involved in aggregation, degradation pathways, and
potential precursors of NM synthesis
The presence of abundant UBC and UBA52 in the NM pigment
inside the NM-containing organelles, as demonstrated by LC-MS
and IEM, suggests that ubiquitinated proteins likely participate in
early steps of NM synthesis in the cytosol. In addition, WB data
demonstrate that high levels of ubiquitinated proteins with high
molecular weight are detected in the NM-containing organelle.
Ubiquitination can direct proteins, particularly when partially
unfolded or damaged, to either proteasome or lysosome; if
proteasome is unable to degrade all ubiquitinated proteins,
macroautophagy could provide an important compensatory
mechanism.91–93
Ubiquitination probably occurs during NM formation attempt-
ing to degrade proteins damaged by DA-modiﬁcation. Proteins
may be modiﬁed by DA-quinones, as we have previously detected
by chemical degradation of NM pigment isolated from SN (TIS-
NM) high amounts of cysteinyl adducts with DA and with 3,4-
dihydroxyphenylalanine (DOPA), in addition to DA and DOPA.3
This suggests that quinones of DA and DOPA are trapped by
cysteine residues of proteins (although histidine residues can
similarly react with quinones), producing DA- and DOPA-modiﬁed
proteins during the early steps of NM biosynthesis. It may be that
ubiquitinated-, NM-derived products are too large to be degraded
by the proteasome and therefore are removed by macroauto-
phagy and ﬁnally stored in the NM-containing organelle (Fig. 8).
We further detected SQSTM1, an important partner of MAP1LC3B,
required for the degradation of ubiquitinated aggregates by
autophagy.94 Interestingly, SQSTM1 accumulates in ubiquitin-rich
inclusion bodies in neurodegenerative protein aggregation
diseases.95,96 The formation of protein inclusion bodies enriched
in SQSTM1 and ubiquitins is a typical response to stress conditions
including amino acid starvation, oxidative stress, and inhibition of
lysosomes and autophagy.94,97,98
Alpha-crystallin B chain and heat shock protein HSP 90-alpha
were found in our samples and could play a role similar to that of
SQSTM1 and ubiquitins during NM-containing organelle forma-
tion. Heat shock protein HSP 90-alpha is a chaperone that
promotes protein folding and might rescue damaged proteins,99
and has been detected also in melanosomes.100 Alpha-crystallin B
chain is a small heat-shock protein that can function as a
molecular chaperone and prevents ﬁbrillization of proteins,
particularly SNCA:31,101 it is sometimes present with ubiquitinated
proteins and SNCA in Lewy bodies,102 and recently was found
markedly upregulated in the SN of PD patients.103 The ﬁnding of
this protein in both the ORG and ORG-NM, but not the TIS-NM
sample, suggests that the protein might not be strictly bound to
NM pigment and is present as a component of the protein matrix
of the NM-containing organelle.
Protein disulﬁde-isomerase A3, a protein found only in TIS-NM
sample and then strictly bound to NM pigment, was also reported
by previous proteomic studies as non-lysosomal protein of NM-
containing organelles.23,24 This enzyme catalyzes disulﬁde bond
formation, reduction, or isomerization and belongs to a family
responsible for quality-control system to ensure the correct
folding of proteins. Interestingly, a member of this family of
proteins was shown to co-localize with SNCA in brainstem and
cortical Lewy bodies of subjects with neurodegenerative
diseases.104
Tubulin polymerization-promoting protein, a protein involved in
the maintenance of microtubule network stability,105,106 plays also
a role in SNCA aggregation and co-localizes with aggregated
SNCA in Lewy bodies inclusions in a group of α-synucleinopa-
thies.30 We found tubulin polymerization-promoting protein in
ORG and ORG-NM samples, suggesting its possible involvement in
NM synthesis and NM-containing organelle formation due to its
reported role in initiating the formation of cellular aggresome-like
structures and inclusion bodies.105
The presence of GPNMB in all isolated samples, as also
conﬁrmed by WB and IEM, is remarkable. The melanosomal
protein GPNMB (refs. 107,108) is found in melanosomes of MNT-1
cells by proteomics analysis,100 participates in melanogenesis,109
and in control of macroautophagy and bulk degradation in the
cytosol, as a recruiter for MAP1LC3B.110 GPNMB could play a role
in formation of NM autophagic vacuoles and fusion to produce
the ﬁnal NM-containing organelle. Notably, its corresponding
gene is a new PD risk loci reported in a wide association meta-
analysis.111 This suggests that mutations of this gene could
encode a modiﬁed GPNMB protein unable to participate in the
macroautophagic process producing the NM-containing orga-
nelle, leaving the neuron exposed to toxic species. A recent gene
expression study on 6-hydroxydopamine animal models of PD
revealed that GPNMB (as well as other genes belonging to
regeneration-associated genes) was highly upregulated in SN
early after the lesion.112 This upregulation could be a response
associated with axodegenerative process of SN neurons after
lesions, and could also exhibit axoprotective or regenerative
properties.112
The lipid bodies of NM-containing organelles contain mainly
dolichols
The lipid bodies in NM-containing organelles contain mostly
dolichols and dolichoic acids, although we did not ﬁnd proteins
for dolichol synthesis or transport, including two important
enzymes for the last steps of synthesis of dolichols (DHDDS and
SRD5A3).113 No dolichol-speciﬁc transporter has been yet
characterized, and only a single study to our knowledge reported
that dolichols intermediates in the human blood are normally
transported by low-density lipoproteins and may be involved in
their accumulation in lysosomes during normal aging and
lysosomal diseases.114 However, we could not detect the receptor
for low-density lipoproteins as representative in our samples.
Dolichols may exist as free forms with free terminal hydroxyl
group, or in phosphorylated forms (dolichol phosphate is required
for glycoprotein biosynthesis), or esteriﬁed with fatty acid, which is
the dominant form of dolichols in animal tissues.113,115 It is
possible that esters of dolichols with fatty acids (dolichols are
usually transported to the lysosomes in the esteriﬁed form)54 are
transferred into NM-containing organelles, where they could be
slowly hydrolyzed to free dolichols by the abundant hydrolase
activities (esterases) we detected. The intracellular accumulation
of dolichyl esters may occur because a majority of lipids are
degraded by cytosolic, lysosomal, and mitochondrial enzymes,
while dolichols are poorly degraded by unknown pathways and
unidentiﬁed speciﬁc catabolic enzymes.116,117 It may be that
dolichols (or dolichyl ester) can be transported into the NM-
containing organelle by vesicle transport and membrane fusion
from other organelles (other NM-containing organelles, lysosomes,
etc.). Indeed, the largest lipid bodies present into the NM-
containing organelles are mainly located on the external portion
of organelle and are membrane bound (Fig. 1a–c), although we
cannot distinguish between a normal bilayer or a single layer; the
smallest lipid bodies are observed both embedded into NM
pigment and in the external portion of the organelle.
Although the precise role of dolichols is not established, they
may be important for membrane trafﬁcking,118 and stimulating
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fusion of lipid vesicles.119 It is possible that dolichol-containing
membranes continuously fuse during NM-containing organelle
formation and maturation (NM-containing autophagosomes with
new lysosomes, with old NM-containing organelles, etc.), and
consequently, dolichols may accumulate in NM-containing orga-
nelles that are unable to efﬁciently degrade them (Fig. 8). Thus,
dolichols in the organelle could derive from incompletely
degraded membranes of other organelles.
The phospholipids and sphingolipids we found in NM-
containing organelles likely derive from the organelle’s own
membranes and incomplete degradation of membranes of
autophagic vacuoles that fuse with NM-containing organelles, as
well as by vesicle transport into NM-containing organelles.
Sulfatides are synthesized and accumulated predominantly in
oligodendrocytes and are a major component in myelin sheaths,
although low amounts of sulfatides have been detected in
neurons and astrocytes.120 The sulfatides accumulated in NM-
containing organelles (at very low level in ORG samples compared
to puriﬁed TIS-NM, see Results) could derive from disruption of
oligodendrocytes, dopaminergic and non-dopaminergic axons
and enter the NM-containing organelles through endocytosis,
vesicle transport and fusion. NM-containing organelles are also
characterized by the presence of some typical neuronal sphingo-
lipids, for example gangliosides (as revealed by LC-MS), which
likely do not undergo complete degradation due to the loss of
activity of glycosyl hydrolases involved in their catabolism,
consistent with the notion that the NM-containing organelles
are a form of aged and impaired lysosomal-related organelle.
NM synthesis begins in cytosol and intermediate products are
transported into organelles
We did not ﬁnd signiﬁcant amounts of typical enzymes and
proteins involved in melanogenesis (i.e., tyrosinase, dopachrome
tautomerase, melanocyte protein PMEL17, etc.),100,121,122 with the
sole exception of the melanosomal protein GPNMB, a glycoprotein
with high homology to the structural melanocyte protein
PMEL17.108,122 In addition to the role suggested above for GPNMB
in autophagy to form the NM-containing organelle, this protein
could produce amyloid ﬁbrils assembling into sheets on which
DA-quinones would start NM synthesis (Fig. 8). Indeed, it was
shown that in the absence of glycosylation, the NTR-PKD domain
region of GPNMB retains the intrinsic capacity to form amyloid in
cell cultures.123
Likewise, we did not ﬁnd DA transporters, with the sole
exception of the synaptic vesicular amine transporter which was
detected at very low levels only in ORG-NM sample and
categorized as non-representative. However, it was shown in the
past that human DA neurons of SN with high levels of NM
pigment have low levels of synaptic vesicular amine transporter
expression and vice versa.12 Similarly, the overexpression of
synaptic vesicular amine transporter in neuronal cell cultures,
treated with L-DOPA which is rapidly converted to DA, inhibited
the synthesis of NM by lowering the cytosolic concentration of
DA.10 It is noteworthy that the protein phosphatase 1 regulatory
subunit 1B, that we found in all samples, is involved in L-DOPA
induced dyskinesia in PD. The L-DOPA increases cytosolic DA and
protein phosphatase 1 regulatory subunit 1B phosphoryla-
tion.124,125 This protein could be involved in the ﬁrst steps of
NM synthesis by reacting with high cytosolic DA and related
catecholamines or their derived products (semiquinones and
quinones), due to the presence of cysteines and histidines in its
structure. Another protein that may react with quinones during
the early steps of NM synthesis could be the cysteine-rich protein
2, which was detected in ORG-NM samples. More broadly,
candidate proteins that could be incorporated into NM pigment
during the early phases of biosynthesis are those containing a
high number of cysteine and histidine groups, which readily react
with quinones.126
It appears that enzymatic (if any) oxidation of DA to form
melanic oligomers occurs in the cytosol, likely via iron catalysis or
by some of the oxidative enzymes (Fig. 8). Evidence for enzymatic
control of the oxidative process leading to NM pigment formation
has been discussed but has not been demonstrated
directly.13,14,127,128 Interestingly, we found two oxidoreductase
enzymes in TIS-NM sample by LC-MS. The ﬁrst is the 3 beta-
hydroxysteroid dehydrogenase type 7 (found exclusively in TIS-
NM sample), which is normally localized in the endoplasmic
reticulum. The other enzyme is the superoxide dismutase [Cu–Zn],
normally found in the cytoplasm, which was found in TIS-NM with
SpC higher than that of the previously mentioned enzyme, and
was also found with slightly higher SpC as fragment in the ORG
sample. This suggests that superoxide dismutase [Cu–Zn] could be
an additional candidate enzyme involved in the oxidation of DA
and related catecholamines during the early phases of NM
synthesis. In addition, the existence of an auto-oxidation process
of DA and related catecholamines must be also considered in the
biosynthesis of NM pigment, a process that to date is only partially
understood. The presence of iron(III) promotes the oxidation of DA
into highly reactive quinones that can form NM pigment.14
Indeed, NM synthesis may be driven by an excess of cytosolic
catecholamines not accumulated in synaptic vesicles, as sug-
gested previously.10 Moreover, the oxidation of DA to semiqui-
nones and quinones can generate aminochrome and 5,6-
indolequinone, which can induce toxicity if these species are
not taken into NM synthesis. These reactive compounds are
reported to cause dysfunction in mitochondria and protein
degradation, and to promote aggregation of SNCA to toxic
protoﬁbrils and produce oxidative damage.129
The melanic component derived from the oxidative polymer-
ization of DA and/or other related catecholamines likely binds to
β-structured proteins, since X-ray scattering studies3 performed on
isolated NM pigment showed a diffraction pattern of about 4.7 Å,
typical of cross-β sheet structured protein aggregates.130 Since
GPNMB and SNCA (both capable of forming insoluble ﬁbrils with
cross β-structure, and WB on ORG samples indicate the presence
of complex aggregates) were found in different parts of the NM-
containing organelle, including NM itself, we propose that NM
formation may start with the accumulation of β-structured protein
aggregates in the cytosol, resulting in the formation of peptide/
protein “seeds”, either protoﬁbrils or even ﬁbrils, which would
react with excess of DA and/or quinones of DA metabolites,131
followed by polymerization to form melanin-protein conjugates.
The protein-DA modiﬁcations and subsequent polymerization was
recently demonstrated in the synthesis of NM models.126,132 The
oxidation of DA and the resulting complex between melanin and
many β-structured proteins, which could include ﬁbrillar forms of
SNCA, GPNMB, and other proteins with cross β-structure,133–135 is
promoted by reactive iron which is abundant in cytosol of SN
neurons.5,14 Iron(III) could accumulate within the conjugates
during this process. Indeed, NM pigment in the organelle binds
iron(III) in two distinct iron-binding sites with different afﬁnity.3,5,14
This ternary complex of iron-melanin-protein formed in the
cytosol can be accumulated into autophagic vacuoles and
transported to the lysosome. Here, the proteases would cleave
most protein chains, generating a complex with higher ratio of
melanin:protein in the ﬁnal NM pigment.3,9 This lower polarity
melanin:protein complex will more easily react with dolichols, and
to a lesser extent with other lipids, released by lipid bodies present
in the organelle to form the insoluble NM pigment which is then
continuously accumulated inside membrane-bound organelles.
This reaction of the complex iron-melanin-protein with dolichols
likely occurs through iron mediated radical oxidation at the
carbon atom adjacent to the double bond in the isoprenic unit of
dolichols.
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We found that dolichols are covalently bound to the melanic
component within the NM structure.3,9,42 The isolated NM
pigment is quite insoluble both in water and organic solvents,
although NM pigment contains a relatively low molecular weight
component that is slightly soluble in dimethyl sulfoxide with
essentially the same composition of the insoluble component.9
The insoluble portion seems to contain polymers of larger size,
more dolichols and less saturated lipids than its dimethyl
sulfoxide-soluble counterpart. The soluble portion of NM pigment
likely consists of oligomeric precursors of polymeric NM that have
molecular weights between 1.4 and 52 kDa.9 The presence of large
amounts of oligomeric and polymeric structures further conﬁrms
that NM synthesis and accumulation are continuous processes
occurring in neuronal organelles (Fig. 8).
CONCLUSIONS
The comparison and integration of data from different methods of
preparation and analysis provide a highly reliable and compre-
hensive description of protein and lipid pathways of NM-
containing organelle of the human SN. We found that the NM-
containing organelle possesses particular membrane and soluble
proteins typical of lysosomes, while other characteristic lysosomal
proteins are missing or scarcely expressed. Typical lysosomal
enzymes abundant in NM-containing organelles are peptidases,
sulfatases and esterases. However, the organelle has lower levels
of lipases and glycosylases than typical lysosomes, and so exhibits
limited degradation pathways for some molecules. The reduced
lysosomal activity and fusion capacity could be a consequence of
inadequate localization of some lysosomal membrane proteins,
including V-type proton ATPase, which normally acidiﬁes
lysosomes.
The LAMP2 is at low levels and inadequately located in NM-
containing organelles, suggesting that lysosomes specialized for
chaperone-mediated autophagy do not form NM-containing
organelles. In contrast, the presence of double membrane
surrounding many of the pigmented organelles and the ﬁnding
of proteins such as MAP1LC3B and SQSTM1 demonstrate the
macroautophagic nature of NM-containing organelles, which
derive from autophagosomes that engulf NM precursors, lipids
and proteins from cytosol.
In lipid bodies of NM-containing organelles, the major
components accumulated are dolichols and dolichoic acids, likely
transported by SCARB2 and APOD. The high accumulation of
dolichols in NM-containing organelles may also be mediated by
membrane fusion from other organelles and vesicle transport of
dolichyl esters, and their subsequent hydrolysis to dolichols.
The NM-containing organelle accumulates undegradable NM
pigment, dolichols, lipids, proteins, and metals over the entire
lifespan. Several proteins have been detected in spite of the
presence of different proteases and other degradative enzymes, as
degradation processes including those dependent on organelle
acidiﬁcation are inhibited or inefﬁcient. Alpha-crystallin B chain
and heat shock protein HSP 90-alpha were found as well as
tubulin polymerization-promoting protein, GPNMB, ubiquitins
(along with several other proteins), likely consistent with their
involvement in macroautophagy and bulk degradation in the
process of NM synthesis.
Among proteins accumulated inside NM-containing organelles,
a striking presence is that of HLA, that could increase the
vulnerability of NM-containing neurons, since this protein can
present antigens on cell membranes so that neurons would be
targeted by T-lymphocytes.
We hypothesize that the NM synthesis starts in the cytosol with
accumulation of aggregated and β-structured proteins, which may
include SNCA, GPNMB, and other proteins, that bind oxidized DA
or DA-derived compounds to produce adducts which undergo
further oxidation and polymerization to form the melanic
component of NM pigment. The protein-melanin conjugate thus
formed traps iron and other metals, and is then accumulated into
autophagic vacuoles and carried to lysosomes. Here, the proteases
likely cleave most of protein/peptide chains of the protein-
melanin conjugate which react with dolichols to form the ﬁnal
NM.
METHODS
Antibodies
For WB and IEM experiments, the following primary antibodies against
different proteins were used: APOD, mouse monoclonal (Abcam, Cam-
bridge, UK); ATP5G1, mouse monoclonal against 18–137 sequence
(Abcam), and this antibody recognizes mature chains of ATP5G1, ATP5G2
and ATP5G3, which are identical in their sequence; ATP6V1B2, mouse
monoclonal (Santa Cruz Biotechnologies Inc., Santa Cruz, CA, USA); CTSD,
goat polyclonal against the C-term (Santa Cruz Biotechnologies); DHDDS,
rabbit polyclonal (Atlas Antibodies AB, Stockholm, Sweden); FTH1, goat
polyclonal (Abcam); FTL, rabbit polyclonal (Abcam); GPNMB, goat
polyclonal against 23–486 sequence (R&D Systems, Minneapolis, MN,
USA); HLA, mouse monoclonal (Santa Cruz Biotechnologies); LAMP1,
mouse monoclonal (Developmental Studies Hybridoma Bank, Iowa City, IA,
USA); LAMP2, mouse monoclonal recognizing all LAMP2 isoforms
(Developmental Studies Hybridoma Bank); MAP1LC3B, rabbit polyclonal
(Cell Signaling Technology, Danvers, MA, USA) and rabbit polyclonal
(Abgent, Inc., San Diego, CA, USA); PLBD2, rabbit polyclonal against
448–565 sequence at C-term (Atlas Antibodies AB); RAB5A, rabbit
polyclonal (Abgent, Inc.); SCARB2, mouse monoclonal (Santa Cruz
Biotechnologies); SNCA, rabbit polyclonal (EMD Millipore, Temecula, CA,
USA); SQSTM1, mouse monoclonal (Abcam); SRD5A3 rabbit polyclonal
(Atlas Antibodies AB); UBA52, rabbit polyclonal against ubiquitin (DakoCy-
tomation, Glostrup, Denmark). We have indicated detailed immunogenic
sequence only for proteins that undergo relevant molecule processing.
Brain tissues
This study was approved by the Institutional Review Board of the Institute
of Biomedical Technologies—National Research Council of Italy (Segrate,
Milan, Italy) and was carried out in agreement with the Policy of National
Research Council of Italy. Written informed consents for using brain
samples for research purposes were obtained from closest relatives and
are stored at the Section of Legal Medicine and Insurances, Department of
Biomedical Sciences for Health, University of Milan, Milan, Italy. Final
approval was given by the pathologist performing the autopsy. All tissues
samples were analyzed anonymously.
In this work, SN samples were obtained during autopsies of male and
female subjects who died at different ages without evidence of
neuropsychiatric and neurodegenerative disorders. The healthy subjects
included in this study at pathological examination did not show any
macroscopic alteration of neurological and vascular type. Histological
examination (on formalin-ﬁxed and parafﬁn-embedded tissue sections)
revealed no Lewy bodies and other pathological markers.
All samples analyzed and included in this study were obtained from
healthy elderly subjects, and the age ranges were the following: (i) ORG
samples for LC-MS and WB analyses of proteins, LC-MS and TLC analyses of
lipids (subjects ranging from 61 to 93 years of age); (ii) TIS-NM samples for
LC-MS analyses of proteins, LC-MS and TLC analyses of lipids (isolated from
pooled SN of subjects ranging from 48 to 92 years of age); (iii) ORG-NM
samples for LC-MS analyses of proteins (subjects ranging from 60 to 82
years of age); (iv) SN tissue lysates for WB analyses of proteins (subjects
ranging from 48 to 89 years of age); and (v) SN tissue slices for IEM
(subjects ranging from 63 to 91 years of age). For each type of preparation
intended for a speciﬁc determination, we have used tissues with similar (as
much as possible) post mortem intervals to use the most reproducible
conditions. It is noteworthy that all the analyses described in this study
were performed on sets of samples coming from subjects with overlapping
age ranges.
Indeed, we were studying brain aging and wanted to investigate elderly
subjects, and in this age range the amount of NM accumulated in SN was
sufﬁcient for our determinations. Furthermore, we employed samples from
subjects in this age range since it was difﬁcult to collect brain samples in a
narrower age range.
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Isolation of NM-containing organelles, NM puriﬁed from SN
tissues, and NM puriﬁed from NM-containing organelles
The isolation of intact ORG samples from SN tissue of single subjects, or
rarely from SN of two subjects depending on the availability of brain
tissues, was performed immediately after SN dissection, in order to avoid
freezing and thawing steps of tissues that otherwise would have altered
the integrity of ORG samples. The isolation procedure of ORG samples was
slightly modiﬁed and adapted for LC-MS analyses from our previously
published protocol.3
TIS-NM samples were isolated from pooled SN tissues and prepared as
previously reported.3,9,42
ORG-NM samples, consisting of the NM pigment fraction isolated from
NM-containing organelles, were prepared from ORG samples and
described as follows. Intact ORG samples suspended in their isolation
buffer3 were processed with three freeze/thaw cycles (−78 °C/+37 °C) in
order to disrupt organelles membranes. The sample was then centrifuged
(17,500 × g, 15 min, 4 °C) to obtain a pellet containing the NM pigment.
This pellet was subsequently washed twice in the same buffer, centrifuged
as described above, and then treated for LC-MS analyses of proteins.
Samples preparation for liquid chromatography-mass
spectrometry analyses of proteins
Samples analyzed by LC-MS for proteomic analyses were isolated from the
following subjects: (i) two ORG samples isolated from two different
subjects (respectively 86 and 69 y.o.); (ii) two TIS-NM samples isolated from
pooled SN tissues, the ﬁrst one from a pool of ﬁve subjects (from 72 to 86
years of age) and the second one from pooled twelve subjects (from 70 to
92 years of age); and (iii) two ORG-NM samples, the ﬁrst one isolated from
one subject (82 y.o.) and the second one from two pooled subjects (60 and
69 y.o.).
TIS-NM samples (dried NM pigments) were hydrated in bi-distilled water
under gentle shaking for 3 days in order to obtain a homogeneous
suspension in water for tryptic digestion. The resulting TIS-NM suspension
was then concentrated (Concentrator 5301; Eppendorf, Hamburg, Ger-
many). ORG samples were concentrated in their isolation buffer while ORG-
NM was directly treated with RapiGest SF (Waters, Milford, MA, USA) as
detailed below.
In order to dissolve membrane proteins and break NM pigment in all
samples, a solution of surfactant RapiGest in 100mM (pH 7.9) ammonium
bicarbonate was added to ORG, TIS-NM and ORG-NM samples according to
the manufacturer’s protocol. A ﬁnal concentration of 0.25 % (v/v) of
RapiGest was adjusted with 100mM ammonium bicarbonate (pH 7.9).
Mixtures were then heated at 100 °C for 5 min, cooled to room
temperature and digested overnight at 37 °C by adding sequencing grade
modiﬁed trypsin (Promega, Madison, WI, USA) at an enzyme/substrate ratio
of 1:50 (w/w). An additional aliquot of 0.5 µg trypsin was added in the
morning and digestion was then prolonged for 4 h. The addition of 0.5 %
triﬂuoroacetic acid stopped the enzymatic reaction and subsequent
incubation at 37 °C for 45min completed the acidic hydrolysis of RapiGest.
The water insoluble degradation products were removed by centrifuging
at 13,000 × g for 10 min and supernatants containing digested proteins
were desalted using PepClean C-18 spin columns (Pierce Biotechnology,
Inc., Rockford, IL, USA), concentrated and ﬁnally suspended in 20 µl of 0.1
% (v/v) formic acid.
Liquid chromatography-mass spectrometry analyses of proteins
Three different types of samples (ORG, TIS-NM, ORG-NM) were prepared
from SN tissues (Supplementary Fig. 1): two samples for ORG, two samples
for TIS-NM, and two samples for ORG-NM as described in the previous
paragraph. Each of the two ORG samples was injected three times for LC-
MS analysis, each of the two TIS-NM samples was injected three times,
while one ORG-NM sample was injected two times and the other one was
injected only one time due to its scarce amount.
The multidimensional protein identiﬁcation technology (MudPIT)
system46,136 is a 2DC-MS/MS platform, composed of a two dimensional
micro-high performance liquid chromatography system (Surveyor HPLC;
Thermo Fisher Scientiﬁc, Inc., San Jose, CA, USA) coupled online to a mass
spectrometer, using ProteomeX-2 conﬁguration (Thermo Fisher Scientiﬁc,
Inc.). Brieﬂy, digested peptide mixtures were loaded onto a capillary strong
cation exchange column (Biobasic-SCX column, 0.32 i.d. × 100mm, 5 µm;
Thermo Fisher Scientiﬁc, Inc.) and eluted stepwise with ammonium
chloride injections of increasing molarity (5, 10, 15, 20, 30, 40, 80, 120, 400,
600, 700 mM). Fractions were captured in turn onto peptide traps (Zorbax
300 SB-C18, 0.3 i.d. × 5mm, 5 µm, 300 Å; Agilent Technologies, Santa Clara,
CA, USA) for concentration and desalting prior to ﬁnal separation by
reversed phase C18 column (Biobasic-18, 0.180 i.d. × 100mm, 5 µm, 300 Å;
Thermo Fisher Scientiﬁc, Inc.). Peptides were eluted using an acetonitrile
gradient (eluent A, 0.1 % formic acid in water; eluent B, 0.1 % formic acid in
acetonitrile): the gradient proﬁle was 5 % eluent B for 3 min, 5–40 % B in
50min, 40–80% B in 10min, 80–95 % B in 5min, 95 % B in 10min.
The ﬂow rate was 100 μl/min, which was split to achieve a ﬁnal ﬂux of 2
μl/min. Then, eluting peptides were electrosprayed directly into a hybrid
ion trap-Orbitrap mass spectrometer (LTQ Orbitrap XLTM ETD; Thermo
Fisher Scientiﬁc, Inc.), equipped with a nanospray ion source. The spray
capillary voltage was set at 1.5 kV, and the ion transfer capillary
temperature was maintained at 220 °C. For each step of peptide elution
from C18 column, full mass spectra were recorded in the positive ion mode
over a 400–1600m/z range, with a resolving power of 60,000 (full width at
half-maximum) and a scan rate of 2 spectra/s. This step was followed by
four low-resolution MS/MS events that were sequentially generated in a
data-dependent manner on the top four ions selected from the full MS
spectrum, using dynamic exclusion for the MS/MS analysis. In particular,
the MS/MS scans were acquired by setting a normalized collision energy of
35% on the precursor ion and, when a peptide ion was analyzed twice,
applying an exclusion duration of 0.5 min. Mass spectrometer scan
functions and high performance liquid chromatography solvent gradients
were controlled by the Xcalibur data system version 1.4 (Thermo Fisher
Scientiﬁc, Inc.).
Identiﬁcation of proteins detected by liquid chromatography-mass
spectrometry analyses
Protein identiﬁcation was carried out by matching experimental spectra to
peptide sequences using the SEQUEST database search algorithm,
contained in BioWorks version 3.3.1 SP1 (University of Washington,
licensed to Thermo Fisher Scientiﬁc, Inc.) using SEQUEST PC Cluster.137
For peptide matching, an updated non-redundant human protein
sequence database of 276,790 entries, downloaded in January 2009 from
the National Center for Biotechnology Information (NCBI) website (http://
www.ncbi.nlm.nih.gov), was used. In addition, to make a thorough
comparison of our data with data obtained from other studies23,24,38 and
to avoid possible bias and false results due to the use of not-aligned
protein codes, the GI accession numbers of identiﬁed proteins were
updated to those downloaded in April 2017 from the UniProt repository
(http://www.uniprot.org/). Therefore, for these comparisons, we have
considered only one time the few proteins we identiﬁed in our samples
by two different GI accession numbers but with same UniProt accession
number.
Known abundant contaminating proteins such as keratins, trypsin and
typical abundant proteins of red blood cells (rarely observed as probable
contaminants in ORG samples) were removed prior to the ﬁnal data
analysis, referring to published proteomic data sets of red blood cells.47,48
HLA peptides were identiﬁed using the updated non-redundant human
HLA isoform (HLA gene) database20 downloaded from NCBI.
This analysis enabled the identiﬁcation of peptide sequences and
related proteins. Since the conﬁdence of protein identiﬁcation depends on
the stringency of the identiﬁcation of the peptide sequence and peptide
matching, particularly when using data from a single peptide, a high
stringency was guaranteed by using the following method. The peptide
mass search tolerance was set to 1.00 Da; the precursor ion tolerance was
set to 50 ppm and the intensity threshold was set to 100. Moreover, all
searches were performed with no enzyme and in order to assign a ﬁnal
score to the proteins, the SEQUEST output data were ﬁltered by setting the
peptide probability to 1 × 10−3, the minimum correlation score values
(Xcorr) was chosen greater than 1.5, 2.0, 2.5, and 3.0 for single-, double-,
triple-, and quadruple-charged ions respectively, and the consensus score
higher than 10. False-positive peptides ratio, calculated through reverse
database, was less than 5%. For decoy searches a reversed version of the
target human protein database was generated using the reverse database
function in Bioworks 3.3.1 software (Thermo Fisher Scientiﬁc, Inc.). The
number of peptides, notably the SpC, detected by MS/MS was utilized as
indicator of relative protein abundance. The group of representative
proteins was selected considering proteins detected by SpC ≥ 2 as average
value in at least one of the three types of samples.
The area-proportional Euler diagrams were calculated using the
eulerAPE drawing tool (software at http://www.eulerdiagrams.org/
eulerAPE/).138 Analyses of proteins for Euler diagram calculation in ORG,
TIS-NM, and ORG-NM, as shown in Fig. 3, were performed by using NCBI
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accession (GI number). Euler diagram calculation in the comparison of our
list of proteins with those previously reported for NM-containing
organelles of human SN23,24 and for human brain lysosomes38 were
performed by using UniProt accession number.
Individual cellular location was assigned to each protein according to
the GOA database (http://geneontology.org/), the UniProt database (http://
www.uniprot.org/) and authors’ PubMed search. It should be noted that
some proteins may have multiple cellular location: in these cases the most
typical and representative cellular location was manually assigned. We
were unable to assign the cellular location for some proteins which were
therefore classiﬁed as “unknown cell location” and additional proteins
without a complete characterization at the moment of data analysis were
classiﬁed as “uncharacterized proteins”.
The names of genes and proteins described in the main text and
supplementary ﬁles were retrieved from updated UniProt and UniParc
database (April 2017), and we adopt as the protein name symbol that of
the approved gene symbol.
Samples preparation for liquid chromatography-mass
spectrometry analysis of lipids
Samples analyzed by LC-MS for identiﬁcation of lipids were isolated from
the following subjects: (i) two TIS-NM samples isolated from pooled SN
tissues, the ﬁrst one isolated from a pool of seven subjects (from 71 to 85
years of age) and the second one from pooled four subjects (from 82 to 85
years of age); (ii) three ORG samples, two of which isolated from two
different subjects (respectively 81 and 89 y.o.) and the third one from two
pooled subjects (74 and 89 y.o.).
The extraction of total lipids from TIS-NM samples was performed by
using methanol and hexane as previously reported.3,9,42 The organic
fractions (methanol and then hexane) derived from NM pigments were
combined and dried under nitrogen ﬂow.
The total lipids were extracted from ORG samples with methanol and
hexane, as for TIS-NM samples. The ORG samples in few µl of isolation
buffer were resuspended in about 0.5 ml of methanol and then centrifuged
(1000 × g, 30 min, 20 °C). The supernatant was collected and the remaining
pellet was resuspended in about 0.5 ml of hexane, and subsequently
centrifuged as described above. Again, organic fractions (methanol and
then hexane) extracted from ORG samples were ﬁnally combined and
dried under nitrogen ﬂow.
Liquid chromatography-mass spectrometry analysis of lipids
For LC-MS analysis, the dried lipids extracted from TIS-NM and ORG
samples were dissolved in 100 µl chloroform and diluted 1:1 (v/v) in eluent
A, as described below. Typically, 5 µl of sample were injected on a C8
reversed phase column (BioBasic C8, 100 × 0.18mm, 5 µm, 300 Å; Thermo
Fisher Scientiﬁc, Inc.), using a micro liquid chromatography system
(Surveyor HPLC; Thermo Fisher Scientiﬁc, Inc.) coupled to a mass
spectrometer with OrbitrapTM mass analyzer (Exactive Plus; Thermo Fisher
Scientiﬁc, Inc.), equipped with a nanospray ion source. Liquid chromato-
graphy was operated at a ﬂow rate of 100 μl/min, split in order to achieve a
ﬁnal ﬂux of 2 μl/min, with a gradient as follows: 100% eluent A was held
isocratically for 10min, then linearly increased to 100% B over 30min and
held at 100% B for 12min. Eluent A consisted of methanol-acetonitrile-
aqueous 1mM ammonium acetate (60:20:20, v/v/v). Eluent B consisted of
isopropanol-acetonitrile (90:10, v/v).
Nanospray was achieved using a coated fused silica emitter (360 µm o.
d./50 µm i.d. 730 µm tip i.d.; New Objective, Inc., Woburn, MA, USA) held to
1.5 kV. The heated capillary was held at 220 °C. Full mass spectra were
recorded in negative and positive ion mode over a 400–2000m/z range.
The resolution was set to 100,000 with 2 microscans/s, restricting the
Orbitrap loading time to a maximum of 50ms with a target value of 5E5
ions (ultimate mass accuracy mode).
Manual interpretation of mass spectra was performed to evaluate the
major lipid species present in the analyzed lipid extracts.
Lipids extraction and partitioning for thin-layer chromatography
analyses of lipids
Samples analyzed by TLC for identiﬁcation and semiquantitative assess-
ment of lipids were isolated from the following subjects: (i) four TIS-NM
samples isolated from pooled SN tissues, the ﬁrst three samples isolated
from a pool of ﬁve subjects each (respectively from 48 to 85 years of age,
from 67 to 85 years of age, from 73 to 85 years of age) and the fourth
sample from pooled four subjects (from 62 to 86 years of age); (ii) three
ORG samples, each of which isolated from one subject (respectively 62, 61,
and 77 y.o.).
Total lipids extracts for TLC analyses were prepared from TIS-NM
samples as previously described by using methanol and hexane.3,9,42
Additionally, these TIS-NM lipids extracts dried under nitrogen stream were
then resuspended in chloroform-methanol-water (2:1:0.1, v/v/v) and
subjected to a two-phase Folch’s partitioning, resulting in the separation
of an aqueous phase containing gangliosides and an organic phase
containing all other lipids, including glycerophospholipids, neutral glyco-
sphingolipids and sphingomyelin.
The ORG samples in few µl of isolation buffer were snap frozen and then
lyophilized. Lipids were extracted with chloroform-methanol-water (2:1:0.1,
v/v/v). Then, total lipid extracts were subjected to a two-phase Folch’s
partitioning.
Following the two-phase partitioning, organic phases deriving from total
lipids extracted from both TIS-NM and ORG samples were analyzed by TLC,
loading equivalent amounts of lipids. Lipids were separated by mono-
dimensional high performance TLC silica gel using chloroform-methanol-
0.2 % aqueous calcium chloride (60:35:8, v/v/v) as a solvent system. After
separation, lipids were detected by spraying the TLC plates with
anisaldehyde, a reagent for the general detection of lipids. Identiﬁcation
of lipids after separation and chemical detection was assessed by co-
migration with lipid standards (Avanti Polar Lipids, Inc., Alabaster, AL, USA;
Sigma-Aldrich Co., St. Louis, MO, USA; some standard were synthesized in
laboratories of the Department of Medical Biotechnology and Translational
Medicine, University of Milan, Segrate, Italy).
Cholera toxin staining of lipid present in the aqueous phases was
performed as described hereafter. Brieﬂy, after chromatographic running
using chloroform-methanol-0.2 % aqueous calcium chloride (50:42:11, v/v/
v) as a solvent system, the TLC plate was well dried and ﬁxed with a
polyisobutylmethacrylate solution prepared dissolving 1.3 g of polyisobu-
tylmethacrylate in 10ml chloroform and diluting 8ml of this solution with
42ml of hexane. The TLC plate was immersed three times in this solution
and then allowed to dry for 1 h. The dried TLC was soaked for 30min in
0.1 M Tris-hydrochloride (pH 8.0), 0.14 M sodium chloride containing 1%
bovine serum albumin. The TLC was then incubated with Clostridium
perfringens sialidase (0.12 U/ml in 0.05 M acetate buffer pH 5.4 and 4mM
calcium chloride) overnight at room temperature. Afterward, the TLC was
incubated with biotin-conjugated cholera toxin subunit B (10 μg/ml;
Sigma-Aldrich Co.) in phosphate-buffered saline containing 1 % bovine
serum albumin for 1 h, and subsequently for 1 h with horseradish
peroxidase-conjugated streptavidin (2 μg/ml; Sigma-Aldrich Co.) in the
same solution. After several washings with phosphate-buffered saline, the
TLC plate was developed for 5 min with o-Phenylenediamine dihydrochlor-
ide substrate (Sigma-Aldrich Co.), 1 tablet in 50ml citrate-phosphate buffer
(pH 5.0) and 20 μl hydrogen peroxide.
Electron microscopy
Transmission electron microscopy for morphological evaluation was
performed on SN tissue slices and isolated ORG samples prepared
according to our previously published method.3
IEM experiments were carried out on SN tissue blocks which were ﬁxed
for 2 h at 4 °C in a mixture of 4 % paraformaldehyde and 0.25 %
glutaraldehyde in cacodylate buffer (0.12 M, pH 7.4). Tissue samples were
extensively washed with cacodylate buffer, dehydrated in a graded
ethanol series and then embedded in LRW resin. Ultra thin sections
(80 nm) were prepared using a ultramicrotome (Leica Ultracut; Leica
Microsystems GmbH, Wien, Austria), collected over nickel grids and
incubated for 90min at room temperature with primary antibodies diluted
in phosphate-buffered saline (pH 7.4). The concentrations of primary
antibodies used for IEM experiments were the following: APOD (1:50),
ATP5G1 (1:100), ATP6V1B2 (1:100), CTSD (1:100), DHDDS (1:200), FTH1
(1:250), FTL (1:300), GPNMB (1:100), HLA (1:200), LAMP1 (1:20), LAMP2
(1:20), MAP1LC3B (1:50 for antibody from Cell Signaling Technology; 1:25
for antibody from Abgent Inc.), PLBD2 (1:100), RAB5A (1:100), SCARB2
(1:50), SNCA (1:200), SQSTM1 (1:30), SRD5A3 (1:25), and UBA52 (1:250). The
grids were then washed with phosphate-buffered saline and incubated for
60min with gold-conjugated secondary antibodies (British Biocell Inter-
national, Cardiff, UK) diluted 1:100 in phosphate-buffered saline. After
extensive washing, the grids were post ﬁxed with 1 % glutaraldehyde in
cacodylate buffer. Samples were then stained with saturated uranyl acetate
in water for 5 min, washed and then stained with 3mM lead citrate for
5 min. Finally, the sections were photographed using a transmission
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electron microscope LEO 912AB (Carl Zeiss AG, Oberkochen, Germany)
equipped with a Proscan CCD camera (ProScan, Lagerlechfeld, Germany)
controlled by EsivisionPro software (Soft Imaging System, Münster,
Germany). Electron microscopy was performed at the Advanced Light
and Electron Microscopy BioImaging Center—San Raffaele Scientiﬁc
Institute.
Each protein was investigated by IEM in at least one to three samples
deriving from different subjects, depending on SN tissue availability. Data
of subjects analyzed by IEM are reported in the legends of ﬁgures chosen
as representative of all electron microscopy experiments. Each IEM
experiment was routinely checked for negative controls as described
below: (i) the reaction was performed on SN tissue slices without either
primary or secondary antibody to conﬁrm the absence of gold particles in
the examined sections; (ii) in the presence of primary and secondary
antibodies, the absence of gold particles was veriﬁed in the resin devoid of
tissue; and (iii) the most relevant control we did was to check the absence
of signal in cellular/tissue components where it was not expected. Only
after passing these three negative controls, we evaluated the signal in NM-
containing organelles which we judged as speciﬁc even if represented by
few gold particles.
Western blotting analyses of tissue lysates and NM-containing
organelles
SN tissues were homogenized and sonicated with ﬁve volumes of lysis
buffer as described above. In case of soluble proteins, the lysis buffer was
composed of 50mM Tris-hydrochloride (pH 7.5), 150mM sodium chloride,
0.1 % sodium dodecyl sulfate, 1 % Triton® X-100, and 1% protease
inhibitor cocktail (Sigma-Aldrich Co.). For membrane-bound proteins, the
lysis buffer was composed of phosphate-buffered saline (pH 7.4), 0.1 %
sodium dodecyl sulfate, 1 % Triton® X-100, and 1 % protease inhibitor
cocktail. After short sonication cycles in ice, SN homogenates were
centrifuged at 17,500 × g, 4 °C (30 min for soluble proteins, 10min for
membrane-bound proteins) and the supernatants were collected. From
supernatants, proteins were precipitated by acid treatment to remove
components of buffers that could inﬂuence protein quantitation. Then,
Lowry method was performed on the protein pellets to measure the total
protein concentration in both SN tissue lysates and ORG samples.
For electrophoresis, samples were heated in reducing sample buffer and
then loaded onto 0.75mm thick polyacrylamide mini gels (different pore
sizes, depending on the desired separation of proteins) and separated by
one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophor-
esis (Mini-PROTEAN® 3 Cell; Bio-Rad Laboratories, Inc., Hercules, CA, USA).
Prestained protein markers (New England BioLabs, Inc., Ipswich, MA, USA)
were used as size standards in the electrophoresis. Proteins were then
over-night transferred (Mini Trans-Blot® Electrophoretic Transfer Cell; Bio-
Rad Laboratories, Inc.) to 0.45 µm supported nitrocellulose membranes
(Hybond®-C Extra; Amersham Biosciences, Little Chalfont, UK). Ponceau-S
staining of membranes was performed to check the efﬁciency of proteins
transfer.
For immunoblotting, membranes were blocked for 2 h at room
temperature with fatty acid/globulin-free bovine serum albumin (Sigma-
Aldrich Co.) or skimmed milk, with concentrations ranging from 3 to 8 %,
depending on the properties of investigated protein, antibody speciﬁcity,
etc., in phosphate-buffered saline (pH 7.4) with 0.1 % Tween® 20. Then
membranes were incubated with primary antibodies diluted in blocking
solutions, while temperature and time of incubation varied according to
antibodies speciﬁcity. The concentrations of primary antibodies used for
WB experiments were the following: APOD (1:300), ATP5G1 (1:100),
ATP6V1B2 (1:400), CTSD (1:500), DHDDS (1:1000), FTH1 (1:3500), FTL
(1:2000), GPNMB (1:1500), LAMP1 (1:50), LAMP2 (1:200), MAP1LC3B (1:600),
PLBD2 (1:300), RAB5A (1:1000), SCARB2 (1:600), SNCA (1:1500), SQSTM1
(1:300), SRD5A3 (1:100), and UBA52 (1:200). After washing, membranes
were incubated for 90min at room temperature with horseradish
peroxidase-labeled secondary antibodies with a concentration range
1:2000–1:5000 in block solution (Jackson ImmunoResearch, Inc., West
Grove, PA, USA; EMD Millipore). After extensive washing, the immunor-
eactive species were visualized by SuperSignal® West Pico chemilumines-
cent substrate as described in the manufacturer’s protocol (Pierce
Biotechnology, Inc.). The ﬁlms were exposed for few seconds up to
15min. As a control for aspeciﬁc binding, the same procedure was
executed without primary antibody. When multiple blotting of membranes
was necessary, as in case of loading control with CTSD antibody, the
RestoreTM PLUS Western Blot Stripping Buffer (Pierce Biotechnology, Inc.)
was used according to manufacturer’s protocol, and successful stripping
was conﬁrmed by re-incubating the membranes with the chemilumines-
cent substrate.
The WB analyses in this study are qualitative rather than quantitative.
For the electrophoresis separation of proteins in the samples, we kept an
empty lane between lanes containing SN tissue lysates and those
containing ORG samples in order to avoid contamination leading to false
positive results. For the preparation of ﬁgures, we divided the two lanes of
interest by a thin white line between juxtaposed lanes. It should be noted
that: (i) ORG samples were loaded at high volumes, due to their low total
protein concentration with respect to SN tissue lysates, and because the
concentration procedure of ORG sample produced an insoluble and
untreatable residue from which proteins could be no longer recovered
(high salt composition of the isolation buffer, particular nature of the NM
pigment contained in ORG samples, etc.); (ii) the granular composition of
the NM pigment present in ORG samples could interfere with the initial
electrophoresis run in the stacking gel, thus leading to lateral diffusion of
proteins; and (iii) the contamination of proteins from SN tissue lysate
(largely rich of proteins) to ORG sample was less probable but could not be
excluded and lead as well to false positive results in ORG samples. The total
amounts of proteins loaded into each lane of the gel were then chosen
depending on the availability of the sample (particularly ORG sample), and
on the content of each selected protein in both SN tissue lysates and ORG
samples. The ratios of protein content between SN tissue lysates and ORG
samples for each protein analyzed by WB are reported in the ﬁgure
legends. Note that for ATP6V1B2, GPNMB, and RAB5A proteins, the WB
analyses were performed on SN tissue lysates and ORG samples on
different days, due to the lack of either SN tissues or ORG samples,
depending on human brain tissues availability, and it was sometimes
impossible to run all types of samples at the same time. Relative lanes
where then juxtaposed as previously explained. The use of WB on SN tissue
lysates was chieﬂy employed to assess the speciﬁcity of each antibody for
the target protein as essential information for IEM experiments, and to
verify its presence or absence in the ORG samples (n ≥ 3 for each protein).
Data of subjects from which SN tissue lysates and ORG samples were
prepared are reported in the legends of ﬁgures chosen as representative of
all WB experiments performed on different samples.
Data availability
All relevant data are within the paper and its Supporting Information ﬁles.
However, raw data supporting the results reported in this article are
available upon request.
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